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General introduction
GENERAL INTRODUCTION
Varicose disease of the leg is a long known disease. With its origin in Egypt, the Papyrus Ebers 
(1550 BC), mentions the treatment of ‘serpent shaped dilatations of lower limb veins’. Ever since, 
physicians have tried dierent methods to treat leg varicosis. The most commonly used surgical 
technique in the 20th century was invented by Keller in 1905 and improved by Mayo in 1906, 
using an intraluminal device which could strip the great saphenous vein. Modications of this 
surgical technique were further explored at the end of the 20th century like inversion stripping 
and cryostripping. Although venous disease had the interest of most physicians in the last 
centuries, nowadays venous disease has suered from a lack of interest and support, especially 
in academic centers. Whatever the reason is of this decline in interest, it is undeserved. Venous 
disease accounts worldwide for an enormous morbidity, loss of quality of life and spending of 
a large amount of the healthcare budget. Therefore small modications in surgical techniques 
can result in large nancial gains and improvement in quality of life. Although the treatment of 
the great saphenous vein has moved to a more minimally invasive procedure like endovenous 
thermo ablation, the surgical stripping technique is still the most used method worldwide. 
Papyrus of Ebers
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1.1  ANATOMY OF THE VEINS IN THE LEG
Contrary to the arterial system, the venous system has many anatomical variations. This fact 
accounts for the diculty in the treatment of venous disorders. In a simplied form there are 
three dierent venous systems in the leg; the supercial venous system, the deep venous 
system and the perforating venous system. Blood ows from the supercial system to the 
deep system. The perforating veins connect the supercial system to the deep system, thereby 
‘perforating’ the muscular fascia, hence their name. All veins in the leg have a number of valves 
which direct the blood ow from distal to proximal and from supercial to deep. The only 
exception are the smallest perforating veins (< 1 mm).
The supercial system consists of two important veins which run just beneath the skin. The 
great saphenous vein, which runs on the medial aspect of the leg and drains in the femoral 
vein in the groin region. The other supercial vein is the small saphenous vein which runs on 
the lateral aspect of the leg and drains in the popliteal vein in the knee pit. 
The deep system consists of many veins which run deep in the leg, near the bones and muscles. 
These are the common femoral vein, deep femoral vein, femoral vein, popliteal vein, anterior 
tibial vein, posterior tibial vein, peroneal vein, gastrocnemial veins and soleal veins.
The perforating system consist of many veins, which had historical a name giving to their 
discoverers (e.g. Dodd, Hunter, Cockett). Nowadays perforating veins are named to their 
anatomical location (e.g. medial ankle perforator, medial gastrocnemius perforator).
Simplied anatomy
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1.2 SOCIO-ECONOMIC ASPECTS
The costs of varicose disease of the leg and the loss of quality of life are substantial. Billions of 
dollars are annually spent worldwide on the treatment of (chronic) venous disease of the leg. 
All (surgical) treatment modalities are known to have a high risk of recurrence which results in 
even more costs, morbidity and loss in quality of life. For a long time physicians used incorrect 
outcomes to determine success after treatment of venous disease of the leg. A postoperative 
duplex ultrasound or plethysmography was proof that a treatment was successful or a failure. 
The patient however could still suffer from edema, pain, cosmetically problems which were 
not measured. To address these problems (health specific) quality of life questionnaires were 
developed. Many of these questionnaires measure certain domains in quality of life, like pain, 
social functioning and physical functioning. Although it is a great step forward to center 
the quality of life of patients in the treatment of venous disease, a new problem has arisen. 
These days there are many different questionnaires which are all used in different studies and 
evaluations of therapy. It is very difficult to compare outcomes of different questionnaires which 
all measures different aspects of quality of life. Another problem is that many questionnaires 
are only validated for the English language and cannot be officially used in other languages. 
The task of validating these questionnaires in the correct language should be performed to 
result in the ultimate goal; an uniform international quality of life questionnaire which can be 
used for trials and evaluating the result of (surgical) therapy. 
1.3 THE ETIOLOGY OF VARICOSE DISEASE
The are many theories considering the etiology of varicose disease of the leg. For many years 
physicians were taught that incompetence of venous valves resulted in venous hypertension, 
varicose veins and in some patients venous ulceration. Although this sounds plausible it is an 
oversimplification of the etiology. Why do venous valves become incompetent? Why do some 
patients develop venous ulcers and other patients never? 
Many theories and hypotheses about varicose veins and ulceration do not hold any longer. The 
hypothesis that venous hypertension resulted in hypo-oxygenation of local skin areas thereby 
causing ulceration has been refuted. The hypothesis that local white cell trapping in capillaries 
resulted in ulceration has also been refuted. 
Many proposed risk factors for venous disease like pregnancy and age have not been definitely 
confirmed in epidemiologic studies. A genetic influence however is confirmed in studies.
The main reason that venous valves become incompetent is still unknown. Histological and 
biochemical research have shown that in the majority of patients with varicose disease and 
valve incompetence a inflammatory component is present with leukocytic infiltration.
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New hypotheses for this inflammatory component have been postulated in the past years, 
ranging from derailed endothelial cells, extracellular matrix alterations, cytokine dysregulation, 
matrix metalloproteinases and their inhibitors. Even infection with a pathogen (virus, 
bacterium, prion) has been proposed as the main cause of valve incompetence.
From the first medical notion on varicose disease, 1500 BC, till now it is still unclear what lies at 
the base of this disease. Hopefully further research will eventually shed light on the cause(s) of 
venous disease and will give us a proper treatment.
1.4 OUTLINE OF THE THESIS
This thesis is based on seven publications on the subject of venous cryo surgery and quality of 
life measurement.
In chapter 2, a health specific English quality of life questionnaire (Aberdeen Varicose Vein 
Questionnaire) is validated for the Dutch language for further use in the randomized trial 
which compares cryostripping to conventional stripping.
In chapter 3, the Dutch translated Aberdeen varicose vein questionnaire is tested whether to 
see if it can differentiate between different severity classes of venous disease. The questionnaire 
is also tested if it can measure differences in quality of life before and after (surgical) treatment.
In chapter 4, the various surgical treatment options for the great saphenous vein are reviewed. 
An adapted version of this review for the British Medical Journal describes the treatment of 
superficial venous incompetence.
In chapter 5, the outcomes are evaluated from a randomized trail comparing conventional 
stripping to cryo stripping of the great saphenous vein.
In chapter 6, the various surgical treatment options for incompetent perforating veins are 
reviewed
In chapter 7, the outcomes of cryo perforator surgery are evaluated.
In chapter 8, the outcomes of cryo perforator surgery with a modified cryoprobe are evaluated.
Finally, chapter 9, summarizes the main findings of the preceding chapters.
Chapter 1
16
REFERENCES
1. Historical overview of varicose vein surgery.  
van den Bremer J, Moll FL. Ann Vasc Surg. 2010 Apr;24(3):426-32.
2. Updated terminology of chronic venous disorders: the VEIN-TERM transatlantic interdisciplinary consensus document. 
Eklof B, Perrin M, Rutherford RB, Gloviczki P J Vasc Surg. 2009 Feb;49(2):498-501.
3. Economic and outcomes-based analysis of the care of symptomatic varicose veins.  
Eidson JL 3rd, Atkins MD, Bohannon WT, Bush RL. J Surg Res. 2011 Jun 1;168(1):5-8.
4. Periodontal bacteremia and various vascular diseases. 
Iwai T. J Periodontal Res. 2009 Dec;44(6):689-94.
5. Venous hypoxia: a poorly studied etiological factor of varicose veins. 
Lim CS, Gohel MS, Shepherd AC, Paleolog E, Davies AH. J Vasc Res. 2011;48(3):185-94
Chapter 1
2
VALIDATION OF THE  
ABERDEEN VARICOSE VEIN 
QUESTIONNAIRE
Chapter 2
18
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ABSTRACT
Purpose: To evaluate reliability and validity of the Dutch translated Aberdeen Varicose Vein 
Questionnaire (AVVQ) for measuring health related quality of life (HR-QOL) in patients with 
venous disease in the lower limb.
Methods: The AVVQ consists of 13 questions related varicose veins. This study assessed 
feasibility, reliability and validity of the Dutch translated AVVQ in a sample of 145 patients with 
venous disease of the leg. Test and retest of the Dutch translated AVVQ were performed within 
a 2 week interval.
Results: There was a high test (99%) and retest (97%) response. 
Feasibility; AVVQ showed few missing answers (0.6%) and non-unique answers (0.2%). 
Regarding internal consistency; Cronbach’s alpha exceeded 0.7 indicating a high level of 
concordance between the AVVQ questions (alpha = 0.76). 
Test-retest reliability; Spearman’s rho showed a significant strong association between test and 
retest scores (rho = 0.87). 
Discriminative validity; AVVQ score was able to differentiate between subgroups of patients 
with different severity of venous disease according to the CEAP classification (Mann-Whitney 
U test, p < 0.01).
Conclusions: This study supports applications of the Dutch AVVQ in HR-QOL measurement in 
patients with venous disease in the Netherlands and the Flemish speaking part of Belgium.
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INTRODUCTION
Venous disease in the lower limb accounts for substantial healthcare expenditure in the 
western world.1,2 A disease specific quality of life (QOL) measurement should be included in 
the measurement of outcome to assess the effect of treatment for varicose veins. The Aberdeen 
Varicose Vein Questionnaire (AVVQ) was developed and validated by Garratt for measuring QOL 
in patients with varicose veins of the leg.3,4 There is no translation and validation of the AVVQ 
in any other language. We adapted the AVVQ into Dutch following international guidelines, 
including three independent forward and two backward translations. This is discussed in the 
Methods. To implement the AVVQ in the Netherlands we assessed feasibility, score distribution, 
reliability and known-group validity of the Dutch AVVQ in a sample of patients with venous 
disease of the lower limb.
MATERIALS AND METHODS
The Aberdeen Varicose Vein questionnaire
The questionnaire consists of 13 questions (items) related to lower limb venous disease and is 
shown in Table 1. Question 1 is a diagram, where patients draw the location of their varicose 
veins. Questions 7 and 9 may only be answered with yes or no. The other questions had 
multiple response options. Questions 3 and 9 were answered with frequency of pain and use 
of painkillers. Questions 1, 2, 5, 6, 7, 8 and 9 should be answered for both legs.
Item scores were summed up after recoding the scores, which resulted in a scale score from 
zero to 100, with zero representing the best score, and 100 the worst score.
Adaptation process
The process followed to adapt the AVVQ into Dutch was based on Bullinger.5 In brief, three 
translators, all native speakers in Dutch, independently translated the questions and the 
response options of the original English AVVQ into Dutch. They were instructed to pay 
attention to conceptual rather than literal equivalence, and to choose words and language 
constructions that were as simple as possible. The translators were vascular surgeons. The 
three resulting independent forward translations were compared and discussed in a group 
meeting of the three translators. Differences were documented and discussed until consensus 
was reached about the optimal phrasing of the Dutch AVVQ. This common forward translation 
was then given to two translators who were native speakers in English and fluent in Dutch. 
They each produced a backward translation that was both compared to the original AVVQ 
for conceptual equivalence with the original source version. The analysis was documented 
and necessary adaptations to the Dutch AVVQ version were made. The resulting Dutch AVVQ 
was then administrated to three patients with venous disease of the lower limbs to provide 
qualitative testing of readability and comprehension. Because this qualitative testing revealed 
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no problem with the Dutch AVVQ, it was subsequently administrated in the study population 
to collect data for psychometric analysis. The complete Dutch translated AVVQ is provided in 
the Appendix. It may be used without license fee in scientific projects.
Study population and data collection
All patients who visited our outpatient clinic in Rotterdam, the Netherlands, with venous 
disease of the leg, were asked to participate in this study. No patient refused to participate. 
In total 145 patients were included in 18 months, with at least 20 patients in each C-group 
of the [Clinical-Etiology-Anatomy-Pathophysiology] (CEAP classification), ranging from C1 
to C6 (Table 1).6 All patients received the AVVQ on the day of their outpatient clinic visit 
(questionnaire 1). Questionnaires were filled in at home and returned directly by mail. A second 
copy of the AVVQ (questionnaire 2) was sent to the participants by mail after two weeks and 
was returned as well, to determine the test retest reliability. If patients had a delay in returning 
the questionnaires, a reminder telephone call was made once. No patients were treated for 
their venous disease of the leg between test and retest.
Analysis
Only questionnaires with at least a 90% response to all items were eligible for analysis. In case 
of non-unique responses (more than one response per item), a random selection of either 
response was used. In case of a missing item response the total possible score for that item 
was subtracted from the maximum possible score for the scale. By doing so, a sumscore 
could still be calculated by dividing the total score by the new maximum possible score and 
multiplying by 100. For the items relating to left and right legs, some patients suffering from 
varicose veins in only one leg had a tendency to miss out boxes for the unaffected leg, rather 
than ticking the first box implying no symptoms. If a patient consistently missed out the 
response set for one leg had not drawn in any varicose veins on that leg in question 1 (Figure 
1), their missing responses were coded zero (no symptoms). Evaluation of feasibility consisted 
of the assessment of response rates, and missing/non-unique answers. Score distribution 
was assessed by floor (25% of respondents or more exhibiting the worst possible score) and 
ceiling (25% of respondents or more exhibiting the best possible score) effects. Cronbach’s a 
was used to evaluate internal consistency of the AVVQ.7 This test assesses the average level 
of correlation between questions in a questionnaire. If the questionnaire is measuring a 
specific problem (venous disease of the leg), then there should be a high level of concordance 
between these questions. If a questionnaire is to be reliable, alpha should exceed 0.7. Test-
retest reliability of the AVVQ scores was assessed by Spearman’s correlation coefficient (rho), 
by two sided Wilcoxon’s signed rank tests, and by effect size: d = [mean(a) - mean(b)]/SD at the 
first measurement.8 Effect sizes can be interpreted as follows: d=0.2=0.5 is considered a small 
effect size, d = 0.5-0.8 is considered a medium effect size and d > 0.8 is a large effect size. The 
discriminative ability between subgroups of patients with different severity of venous disease 
was assessed by Mann-Whitney U tests, and effect sizes.8
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RESULTS
Response
Questionnaire 1 was returned by 143 patients (test response 99%). There were no incomplete 
forms. Questionnaire 2 was returned by 140 patients (retest response 97%) with no incomplete 
forms. The five patients who did not return questionnaire 2 included the two patients who 
also did not return questionnaire 1. The age range was 23-85 years (mean 54; SD 13); 69% was 
female. There were at least 20 patients in every C-class of the CEAP classification (Table 1).
Feasibility
The AVVQ showed few missing answers (0.6% on average) and non-unique answers (0.2% on 
average). Some spontaneous remarks were made regarding the first item, in which patients 
had to draw their varicose veins in a picture of both legs (Figure 1) (e.g. ‘there are only varicose 
veins on my ankle and foot’).
Score distributions and internal consistency
Two items of the AVVQ had floor effects. These were items ‘degree of ankle swelling’ (28%) and 
‘any discoloration?’ (45%). None of the items had ceiling effects. Cronbach’s alpha was 0.76.
Test-retest reliability
Mean AVVQ test score was 19.16 (SD 12.09) and mean AVVQ retest score was 19.62 (SD 11.76). 
Spearman’s rho showed a significant strong association between test and retest scores 
(rho = 0.87, p < 0.01). Non-parametric testing for differences between the average AVVQ scores 
at test and retest (two sided Wilcoxon’s signed ranks test) was not significant (p=0.12). The 
effect size was very small (0.04).
Discriminative ‘known groups’ validity
The AVVQ score was able to differentiate between subgroups of patients with different severity 
of venous disease (Mann-Whitney U test, p < 0.01); the effect sizes were large (0.84 and 1.01) 
(Table 2).
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Table 1: The Aberdeen Varicose Vein Questionnaire
1. Please draw in your varicose veins in the diagram below (figure 1).
2. In the last two weeks, for how many days did your varicose veins cause you pain or ache?
3. During the last two weeks, on how many days did you take painkilling tablets for your varicose veins?
4. In the last two weeks, how much ankle swelling have you had?
5. In the last two weeks, have you worn support stockings or tights?
6. In the last two weeks, have you had any itching in association with your varicose veins?
7. Do you have purple discolouration caused by tiny blood vessels in the skin, in association with your 
varicose veins?
8. Do you have a rash or eczema in the area of your ankle?
9. Do you have a skin ulcer associated with your varicose veins?
10. Does the appearance of your varicose veins cause you concern?
11. Does the appearance of your varicose veins influence your choice of clothing including tights?
12. During the last two weeks, have your varicose veins interfered with your work/housework or other daily 
activities?
13. During the last two weeks, have your varicose veins interfered with your leisure activities (including sport, 
hobbies and social life?
14. Do you have purple discolouration caused by tiny blood vessels in the skin, in association with your 
varicose veins?
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Table 2: Preoperative and postoperative AVVQ scores (standard version)
Group Preoperative AVVQ  
score (SD)
Postoperative AVVQ  
score (SD)
pa
All patiens (n = 43) 19.54 (11.77) 16.11 (12.02) < 0.01
Subgroep A (n = 50) 11.12 (5.43) 9.24 (6.56) = 0.01
Subgroep B (n = 50) 18.65 (9.04) 14.96 (9.84) < 0.01
Subgroep C (n = 43) 30.36 (11.57) 25.43 (13.36) < 0.01
Subgroep A: clinical severity classes 1 and 2
Subgroep B: clinical severity classes 3 and 4
Subgroep C: clinical severity classes 5 and 6
a Two-sided Wilcoxon’s signed ranks test.
DISCUSSION
This study established the feasibility, reliability and validity of the AVVQ in a Dutch population 
of outpatients with varicose veins. The psychometric properties of the Dutch AVVQ were similar 
to the original UK version. Score distributions, internal consistency and test-retest reliability in 
the Dutch sample have shown similar results as the UK samples.3,4,9
In the Dutch sample 2 items showed floor effects: ‘degree of ankle swelling’ and ‘any 
discoloration?’. Regarding the former item; many patients in the higher C-classification suffered 
ankle swelling, which accounts for the floor effect in this study. Regarding the latter item; the 
large proportion of patients with small reticular veins may explain the high number of patients 
endorsing this item. Cronbach’s alpha of 0.76 is comparable to internal consistency reported 
by Garrat (Cronbach’s alpha of 0.72-0.74) in a UK sample.3,9
CONCLUSIONS
The current evaluation of the Dutch AVVQ showed properties that are largely comparable 
to those found in similar UK samples. This supports applications of the Dutch AVVQ in QOL 
measurement in patients with venous disease in the Netherlands and the Dutch speaking part 
of Belgium.
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ABSTRACT
Purpose: This clinical trial evaluated the use of the Dutch translated Aberdeen Varicose Vein 
Questionnaire (AVVQ) and SF-36 before and after treatment in patients with clinical-severity 
classes 1-6 venous disease of the lower limb.
Methods: A total of 145 patients with symptomatic venous disease of the leg were included. 
Numbers of patients were evenly distributed among the six clinical-severity classes 1-6 
(clinical, etiology, anatomy and pathophysiology; CEAP). Patients completed two preoperative 
AVVQ questionnaires and one short-form health survey with 36 items (SF-36) questionnaire to 
evaluate test-retest reliability of the AVVQ. Patients completed one postoperative AVVQ and 
SF-36 to evaluate the effect of treatment.
Results: The test (99%) and re-test responses (97%) of the AVVQ were sufficient. Internal 
consistency of the Dutch translated AVVQ showed a Cronbach’s alpha of 0.76. Correlation of test 
and re-test of the AVVQ Q2 was high (rho = 0.86, P < 0.001). A significant negative association, 
by Spearman’s correlation coefficient, was found between the preoperative baseline Dutch 
translated AVVQ score and all eight domains of the preoperative SF-36 (P < 0.001). These 
significant associations were also found in the postoperative scores.
The mean preoperative AVVQ score of 19.5 (SD 11.8) and mean postoperative AVVQ score of 
16.1 (SD 12.0) differed significantly (P < 0.01). Analysis of three subgroups of clinical-severity 
classes (C1-2, C3-4 and C5-6) showed significant score changes before and after surgery 
(P < 0.01). Preoperative and postoperative SF-36 scores were not significantly different.
Conclusions: This study established the use of the Dutch translated AVVQ as a valid, health 
related quality of life (QOL) questionnaire for measuring QOL before and after treatment in 
patients with clinical-severity classes 1-6 venous disease of the leg.
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INTRODUCTION
A large amount of the health-service resources in the Western world is spent on the treatment 
of venous disease of the legs.1,2 Anatomical or physiological tests may not be the best 
outcome measures when procedures are done to palliate symptoms of venous disease. Instead 
of only evaluating the outcome with venous duplex, it is better to assess the effect when it is 
combined with a health-related quality of life (HR-QOL) measurement. The Aberdeen Varicose 
Vein Questionnaire (AVVQ) was developed by Garratt et al., in 1993, for measuring QOL in 
patients with venous disease of the leg.3 The questionnaire consists of 13 items related to 
problems of venous disease of the leg. Generic health status in patients with venous disease 
can be measured with the short-form health survey with 36 items (SF-36). The 36 items results 
in eight domains after recoding related to physical and mental health and social functioning. 
To completely assess the QOL of patients with venous disease, a health-related and a generic 
health status should be obtained to maximize detection of change after treatment. An 
evaluation of preoperative and postoperative AVVQ scores, in combination with SF-36 scores, 
in a cohort of patients with symptomatic varicose veins, but with the exclusion of active venous 
ulceration, has been reported by Smith et al.4 This study aims to test the hypothesis that the 
Dutch translated AVVQ is a useful instrument for measuring HR-QOL in patients with venous 
disease, before and after treatment.
MATERIALS AND METHODS
This study was performed in combination with a validation and reliability study of the Dutch 
translated AVVQ. The study protocol was approved by the local ethics committee. Patients 
who visited our out-patient clinic in Rotterdam, The Netherlands, with symptomatic venous 
disease of the leg were asked to participate in this study. The exclusion criteria were: body 
mass index (BMI) > 40, recurrence of venous incompetence in the great saphenous vein (GSV) 
or small saphenous vein (SSV), occlusion of the deep venous system, peripheral arterial disease 
as indicated by absent pulses and an ankle brachial index (ABI) < 0.9, already being part of the 
study with the contra lateral leg, and the inability to understand the Dutch language. None 
of the patients refused to participate. In total, 145 patients were included, with a minimum of 
20 patients in each group of the clinical-severity classes (C1-C6). Most patients had a primary 
etiology for their venous disease, and only three patients had a secondary etiology (post-
thrombotic). None of the patients had congenital venous disease. Considering anatomy and 
pathophysiology, all patients had reflux to some extent in their superficial venous system. 
Deep venous reflux was found in 42 patients (29%), while perforating vein reflux was found 
in 58 patients (41%). None of the patients had deep venous obstruction. The mean age was 
54 years (range: 23-85 years); 69% of patients were female. All patients received two AVVQs 
preoperatively for test and re-test evaluation, with a two week interval. The AVVQ can have 
a score ranging from 0 to 100, with 0 representing the best score, and 100 the worst score. 
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AVVQs were filled out at home and returned directly by mail. No patients were treated for their 
venous disease of the leg between test and re-test. On the day of hospital admission, patients 
were asked to fill out an SF-36 before treatment. SF-36 scores resulted in eight domains after 
recoding. These were Physical Functioning (PF), Role Limitation due to Physical problems (RP), 
Bodily Pain (BP), General Health (GH), Vitality (VI), Social Functioning (SF), Role Limitation due 
to Emotional problems (RE) and Mental Health (MH).
The scores in the domains range from 0, the worst score, to 100, the best score. Six weeks 
after treatment, patients visited our outpatient clinic for physical examination. Immediately 
after this visit, patients completed their third AVVQ. The SF-36 was given to patients with the 
instruction to fill in the questionnaire at home and return it by mail. This strategy was chosen 
to get maximum postoperative AVVQ responders. The SF-36 took too much time to fill in at the 
out-patient clinic visit; therefore, patients were asked to complete it at home.
Treatment
Obstruction of the deep venous system was a contraindication for surgical treatment.
Patients with clinical-severity class C1 and a duplex proven competent GSV and SSV were treated 
with phlebectomy and sclerotherapy. Phlebectomy was performed under local anesthesia. 
Patients with clinical-severity classes C2-C5 and duplex proven incompetence of the GSV and/
or SSV were treated surgically. The treatment consisted of Babcock stripping of the GSV and/
or ligation and division of the SSV. Patients with clinical-severity class C6 and duplex proven 
incompetence of the GSV and/or SSV and/or perforating veins were treated surgically. Surgical 
treatment consisted of Babcock stripping of the GSV and/or ligation and division of the SSV. 
Sub-fascial endoscopic perforating vein surgery (SEPS) was performed for incompetent 
perforating veins. To increase mobility and decrease the risk of deep venous thrombosis, only 
one leg at a time was treated in all patients. Phlebectomy and/or sclerotherapy in patients with 
C2-C6 venous disease was performed, if necessary, not less than 2-3 months after the surgery. 
All patients received preoperative low-molecular-weight heparin injections and graduated 
elastic compression stockings postoperatively. Conventional stripping of the GSV, ligation and 
division of the SSV and SEPS were performed under spinal anesthesia. This was normal policy 
in our hospital and was not specific to the protocol for this study. Endovenous techniques, 
including radiofrequency ablation and laser ablation, were used in our hospital in separate 
clinical trials. Therefore, none of the patients in this study underwent these newer techniques.
Validation
The validity and reliability of the Dutch translated AVVQ was assessed in this cohort of patients 
and was reported beforehand. Internal consistency was tested using Cronbach’s alpha. This 
is a coefficient of reliability (or consistency), and it assesses the average level of correlation 
between the questions (items) in a questionnaire. If the questionnaire is measuring a specific 
problem (venous disease of the leg), there should be a high level of concordance between these 
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questions. If a questionnaire is to be reliable, alpha should exceed 0.7. Test-retest reliability 
was assessed using the two-tailed Wilcoxon’s signed ranks test. Assessment for discrimination 
between subgroups of preoperative patients with different clinical-severity classes was done 
by Mann-Whitney U-tests.
Analysis
Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS 
15.0) for Windows. Evaluation of the Dutch translated AVVQ and SF-36 before and after 
treatment of leg venous disease consisted of preoperative and postoperative Wilcoxon’s 
signed rank tests. Extra validity was evaluated in this study ;the correlation of AVVQ score and 
SF-36 scores of each of the eight domains using Spearman’s correlation coefficient.
RESULTS
Response
The first AVVQ (preoperative) was returned by 143 patients resulting in a test response of 99%. 
The second AVVQ (preoperative) was returned by 140 patients resulting in a re-test response 
of 97%. The five patients who did not return the second AVVQ included the two patients who 
also did not return the first AVVQ. These two patients also did not show up on their out-patient 
clinic appointments and, thus, were not treated for their venous disease. In this cohort, 143 
patients were treated for their venous disease of the leg. These 143 patients all completed their 
first SF-36 (preoperative) on the day of hospital admission. After a reminder telephone call, 
eventually all postoperative patients attended their out-patient clinic appointment, where all 
patients completed their third AVVQ. Unfortunately, only 118 patients returned their second 
SF-36 by mail, resulting in a response of 83%. 
Internal consistency, test-retest reliability and discriminative validity
Internal consistency testing of the AVVQ showed a Cronbach’s alpha of 0.76.
Mean preoperative AVVQ test score was 19.2 (SD 12.1) and mean preoperative AVVQ re-test 
score was 19.6 (SD 11.8). There was a significant correlation between both preoperative AVVQ 
scores (Spearman’s correlation coefficient, Rho = 0.86, P < 0.01).
No correlations were observed for AVVQ score compared to patients age or gender. The 
preoperative AVVQ score was able to differentiate between subgroups of patients with 
different clinical severity classes; C1-C2, C3-C4 and C5-C6 (Mann-Whitney U-test, P < 0.01).
Correlation of the AVVQ and SF-36
Because of the small differences in scores between the first and second AVVQ (both 
preoperative), the mean score of both questionnaires was used as a preoperative baseline 
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AVVQ score. In three patients we did not receive a second preoperative AVVQ; therefore, we 
used their first AVVQ as a baseline preoperative AVVQ score. A significant negative association, 
by Spearman’s correlation coefficient (rho) was found between the baseline preoperative 
Dutch translated AVVQ score and all eight domains of the preoperative SF-36. Three of the four 
highest associations (rho < -0.4, P < 0.01) were found in the physical domains: PF (rho = -0.541, 
P < 0.01), RP (rho = -0.448, P < 0.01), BP (rho = -0.439, P < 0.01) and the remaining high 
association in SF (rho = -0.412, P < 0.01). These significant associations were also found in the 
postoperative scores. 
Preoperative and postoperative AVVQ scores
The mean preoperative baseline AVVQ score was 19.5 (SD 11.8) and mean postoperative AVVQ 
score was 16.1 (SD 12.0). A two-tailed Wilcoxon’s signed ranks test was significant (P < 0.01) 
for the differences between preoperative and postoperative AVVQ scores. We examined 
preoperative and postoperative AVVQ scores of three subgroups of patients with different 
clinical severity scores. These three subgroups are as follows:
 – Subgroup A: clinical-severity classes C1 and C2 (n=50)
 – Subgroup B: clinical-severity classes C3 and C4 (n=50)
 – Subgroup C: clinical-severity classes C5 and C6 (n=43)
Because of small numbers of patients in subgroup-analyses we combined two clinical-severity 
classes in each subgroup (Table 1). In all these subgroups, we found significant changes in the 
mean preoperative AVVQ score and mean postoperative AVVQ score (Wilcoxon’s signed ranks 
test).
Table 1: Preoperative and postoperative AVVQ scores (standard version) 
Group Preoperative AVVQ  
score (SD)
Postoperative AVVQ  
score (SD)
pa
All patiens (n = 143) 19.5 (11.8) 16.11 (12.0) < 0.01
Subgroep A (n = 50) 11.1 (5.4) 9.24 (6.6) = 0.01
Subgroep B (n = 50) 18.7 (9.0) 15.0 (9.8) < 0.01
Subgroep C (n = 43) 30.4 (11.6) 25.4 (13.4) < 0.01
Subgroep A: clinical severity classes C1 and C2
Subgroep B: clinical severity classes C3 and C4
Subgroep C: clinical severity classes C5 and C6
a Two-sided Wilcoxon’s signed ranks test.
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Preoperative and postoperative SF-36 scores
Seven of the eight domains of the SF-36 had higher postoperative scores. The domain ‘social 
functioning’ had a lower postoperative score. Preoperative and postoperative SF-36 scores 
were not significantly different (Wilcoxon’s signed ranks test). There was a trend of a higher 
postoperative score in the domains ‘physical functioning’ and ‘vitality’, but significance was not 
reached in both domains (Table 2).
Table 2: Preoperative and postoperative SF-36 domain scores
Domain Preoperatively Postoperatively Pa
PF 71.4 78.3 0.055
RP 66.8 71.4 0.96
BP 66.9 74.0 0.19
GH 67.7 71.9 0.64
VI 64.1 69.8 0.059
SF 82.5 81.8 0.19
RE 77.2 79.9 0.61
MH 54.2 57.6 0.71
a Two-tailed Wilcoxon signed ranks test.
Complications
There was no major complication. There were six patients with a wound infection that healed 
with conservative treatment. Four of these patients had C2, and two patients had C4, venous 
disease.
DISCUSSION
Response
The response rate of the preoperative and postoperative AVVQ was very good. This was due to 
the fact that we asked patients to complete the postoperative AVVQ in the outpatient clinic, and 
that it took around 5 min to complete the questionnaire. The response rate of the preoperative 
SF-36 was very good because patients had to complete the questionnaire in the hospital on 
the day of their admission. The postoperative SF-36 response was disappointing (83%). A 
reason could be that patients could complete this questionnaire at home. The reason why so 
many patients did not return their last SF-36 is speculative. Patients could have forgotten to 
complete the questionnaire or were ‘questionnaire-tired’ after completing a lot of the same 
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questionnaires in a relatively short time. In a similar study, Smith also found an 80% of patients 
lost to follow-up; these patients did not show up on their out-patient clinic appointment.4
Validity and reliability
Internal consistencies, test-retest reliability and discriminative validity of the Dutch translated 
AVVQ and original AVVQ have been tested and reported before.3,5 The original AVVQ and 
Dutch translated AVVQ showed good validity and reliability.
Correlation of AVVQ score and SF-36 score
There was a significant negative association of preoperative AVVQ scores and the eight 
domains of the preoperative SF-36. Smith found only four domains to be significant.4 These 
were exactly the same four domains which showed the strongest association in this cohort of 
patients. Three of these domains were physical domains: ‘physical functioning’, ‘role limitation 
due to physical problems’ and ‘bodily pain’, which was expected because the AVVQ has many 
questions about physical discomfort and pain. The remaining domain, ‘social functioning’, also 
showed a strong association and was expected because the last two questions of the AVVQ are 
related to social functioning, which was also reported previously.5 The significant association 
of the eight domains gives extra validity to the Dutch translated AVVQ as an instrument to 
measure HR-QOL.
Preoperative and postoperative AVVQ scores
A highly significant decrease in postoperative AVVQ scores was found in this cohort. Smith 
found similar results only with lower preoperative and postoperative AVVQ scores.4 
This is almost certainly due to the fact that patients with active venous ulceration were excluded 
in their study. This is the group of patients with the highest AVVQ scores. We also found a 
significant decrease in postoperative AVVQ scores in the three subgroups with different clinical 
severity classes.
Preoperative and postoperative SF-36 scores
We found no significant increase in postoperative scores in any of the eight domains of the 
SF-36. There was a trend of a higher postoperative score in the domain ‘physical functioning’ 
which is to be expected because, after treatment, patients will have less physical complaints 
of their venous disease, like a heavy and tired feeling in the leg, pain and ankle swelling. The 
domain ‘vitality’ also showed a trend of a higher postoperative score; this domain is also known 
as ‘energy’ and patients could feel better because of a decrease in physical discomfort. Smith 
et al. found a significant increase in the domain ‘mental health’.4 Remarkably, this is the only 
domain that has a very different preoperative score in the Dutch cohort (mean 54.2) compared 
to the UK cohort (mean about 70). This could be due to a chance or a real difference between the 
samples because of the exclusion of patients with active venous ulceration in the UK sample. 
These patients scored the worst in this study on the domain mental health. The other seven 
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preoperative domain scores were similar to the UK cohort. The domain ‘social functioning’ had 
a non-significant, lower postoperative score. It is reasonable that patients treated for venous 
disease will engage less in social activities, such as sports, or other leisure activities for a few 
weeks. Therefore, a slightly lower score was expected in this domain.
CONCLUSIONS
Treatment of venous disease of the leg can increase QOL. Patients with venous disease of the 
leg have specific clinical complaints. The SF-36 is a measurement of generic health status; 
therefore, it cannot fully detect these specific clinical complaints. The AVVQ was designed a year 
before the introduction of the CEAP-classification system. Although the name ‘AVVQ’ suggests 
an instrument which measures HR-QOL in patients with only varicose veins (C1 and C2) this 
study shows that it can be used for the whole spectrum of venous disease (C1-C6). Contrary 
to the SF-36, the AVVQ can measure the specific clinical complaints in patients with venous 
disease. This study established the use of the Dutch translated AVVQ as a valid questionnaire 
for measuring preoperative and postoperative HR-QOL in patients with clinical-severity classes 
C1-C6 venous disease.
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INTRODUCTION
Varicose veins are a common medical problem and often encountered in surgical practice. 
Prevalence is rising with an increasing age. At the age of 40 years, 40% of women and 25% 
of men have varicose veins. At the age of 70 prevalence has increased to 60%.1-3 The high 
prevalence of venous disease of the leg accounts for enormous costs and loss of quality of 
life worldwide.4-6 The major cause of venous disease is incompetence of the saphenofemoral 
junction (SFJ) and the great saphenous vein (GSV).7
In the last decade several minimally invasive endovenous treatment options for GSV 
incompetence have become increasingly popular. These new techniques includes endovenous 
laser ablation (EVLA), radiofrequency ablation (RFA) and endovenous steam ablation (ESVA).8,9 
Nevertheless the most commonly used surgical treatment is still high ligation at the SFJ 
followed by a short stripping to the knee.10,11 Potential advantages of endovenous techniques 
include a reduction in postoperative morbidity, a shorter recovery period and an improved 
cosmetically result.
The objective of this review is to describe the most commonly used procedures, results and 
complications for treatment of GSV incompetence. Despite the large numbers of procedures 
done annually for varicose veins, only a few randomized controlled trials with endovenous 
procedures have been published. Most of them have small numbers of included patients with 
short term follow up. Neither investigators nor patients were blinded to the treatment method 
in the randomized trials discussed in this paper.
METHODS
The literature was searched according to the international guidelines for evidence based 
research to identify studies describing the surgical treatment of the GSV over the period from 
January 1985 till June 2011. We carried out an electronic search of Medline and Embase. The 
medical subject heading (MeSH) term “saphenous OR varicose” was used. This very broad search 
strategy guaranteed that all possible relevant articles were reviewed. The search was limited to 
English articles only. All the selected papers were reviewed by two independently physicians. 
Included papers provided data on patients with primary venous reflux confirmed by duplex 
ultrasound. Effectiveness of treatment was assessed by abolition of reflux, recanalization, 
reduction of symptoms and quality of life.
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RESULTS
Conventional stripping of the GSV
Conventional surgical treatment for varicose veins due to reflux in the GSV is ligation at the SFJ 
and its tributaries, followed by a short stripping of the GSV from the groin to knee level.12,13 
This is a day case procedure that requires general or spinal anaesthesia. A few centers use local 
anaesthesia (tumescent anaesthesia) these days. Variations to the classic approach, using an 
acorn tip mounted on the stripper, include the use of inversion strippers. Surgical stripping is 
one of the most performed procedures in general surgery over the past decades, but there is 
only little evidence available. 
Results
Three randomized trials compare the inversion technique with the conventional technique 
and show no difference in the extent of bruising or pain.14-16 They report a significantly 
smaller exit wound using the inversion stripper,15,16 and lower rates of paresthesia following 
an invagination stripping.15 
Recurrence rates vary, depending on definition and length of follow up. After surgery recurrence 
rates on duplex ultrasound are 13 to 29% with a follow up of 2 to 5 years.17-19 A study with 
a mean follow up period of 34 years showed recurrence on duplex ultrasound in 60% of 125 
limbs after surgery, mostly due to neovascularisation.20 
Complications 
Problems arising from varicose vein surgery are the single most common reason for litigation 
in the UK.24 Most settled claims result from a failure to warn patients for nerve damage. A short 
stripping, from groin to knee level, proposes a far less risk for nerve damage compared to a 
groin to ankle stripping. Nerve damage is then reduced from 40% to 8%.25-27 
Deep vein thrombosis (DVT) poses a risk for pulmonary embolism. Based on clinical grounds, 
the incidence is thought to be 0.5%.28,29 van Rij et al assessed 377 legs after surgery by duplex 
ultrasound.30 DVT was detected in 5% of the patients. The majority was confined to the calf 
veins and no patient developed a pulmonary embolism. Although the incidence of DVT 
following varicose vein surgery was higher than previously thought, there was minimal short- 
or long- term clinical significance. Hematoma formation is common after stripping the GSV. 
Wound infection occurs in about 10% and is responsible for delayed return to normal activity 
and work.31 Another complication is the formation of a lymphocele or lymphoedema of the 
leg.
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Cryo stripping of the GSV
Cryo stripping was popular in France, Germany, The Netherlands and Eastern Europe around 
1990 till 2000. Cryo stripping is a day case procedure that requires general or spinal anaesthesia. 
After SFJ ligation and its tributaries, the cryoprobe is advanced intraluminal in the GSV from 
groin level towards the knee. A separate incision near the knee is not necessary which was the 
main cosmetic reason to use cryostripping. After freezing for 10 seconds (liquid dinitrousoxide, 
-89 degrees Celsius), vigorously pulling the probe results in ‘breaking’ of the frozen GSV at knee 
level. While freezing, the cryoprobe is slowly pulled back towards the groin, thereby stripping 
the GSV in the upper leg. 
Results
Two randomized trials comparing cryostripping to conventional stripping were performed.32,33 
In a large, well organized trial, 494 patients were randomized for either conventional stripping 
or cryostripping of the GSV. The primary outcome of this trial was residual GSV, 6 months after 
surgery. Secondary endpoint was quality of life. Considering residual GSV after cryostripping: 
the percentage of patients with residual GSV at 6 months was 44% in the cryo group and 15% in 
the conventional group (difference 29%; P < 0.01). Regarding quality of life after cryostripping 
in both studies: scores showed no significant change between cryostripping and conventional 
stripping. 
Complications
Compared to conventional stripping, in these two studies there were no more or different 
complications observed in cryostripping. 
Endovenous procedures
RFA, EVLA and ESVA are catheter based endovenous procedures in which thermal energy is 
delivered into the vein wall of the GSV. The GSV is cannulated adjacent to the knee under 
duplex ultrasound guidance. A catheter is inserted over a guidewire. The tip of the catheter is 
positioned 2 cm distally to the SFJ. After administration of perivenous tumescent anaesthesia 
the laserfiber, RFA catheter or steam catheter is introduced. Perivenous tumescent anaesthesia 
is applied to decrease pain and prevent neural damage and skin burn.34 These procedures do 
not require spinal or general anaesthesia and can be performed in a outpatient setting. 
Radiofrequency ablation (RFA)
The most commonly used device is the ClosureFast catheter (VNUS Medical Technologies 
Inc, Sunnyvale, CA). Local tissue is heated up to 90˚C at the site of contact. Vein wall collagen 
contraction in response to thermal energy causes immediate vein wall thickening and lumen 
reduction. Endothelium destruction and an inflammatory response followed by fibrosis result in 
permanent occlusion.35,36 A thermocouple located on the catheter monitors the temperature 
and provides feedback to the generator, which, in turn, controls the power delivery and 
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the treatment temperature. The thermocouple also monitors impedance. Control of energy 
delivery is an important feature of the RFA technique. 
Results
Three randomized clinical trials have compared RFA with surgical stripping of the GSV. The 
EVOLVeS trial is a multicenter prospective randomized trial sponsored by the manufacturer 
with 80 procedures. They reported significant early advantages, mainly on patient recovery.37 
Patients undergoing RFA showed a quicker return to normal activity; 1.15 days compared to 
3.89 days. Mean duration of the time to return to work were also in favour of the RFA group, 
4.7 days compared to 12.4 days in the conventional stripping group. Quality of life analysis 
showed superior outcome in the RFA group for global score and pain score between 1 week 
and 4 months. Clinical outcomes were also evaluated with a two year follow up period. Clinical 
and hemodynamic outcomes and varicose vein recurrence rates were similar for both groups 
at 2 years.38 In a second, smaller trial Rautio et al randomized 28 patients between RFA and 
conventional stripping.39 These patients were followed up at 3 years post procedure.40 
Significantly less post operative pain was reported and shorter sick leaves and faster return to 
normal activities. There was no difference in the quality of life scores between the two groups 
following treatment. The results of these two randomized trials are possibly flawed by their low 
number of included patients. Elkaffas et al randomized 180 limbs with a follow up of 2 years 
and reported equal recurrence rates.41 Primary occlusion rates were 95% in the RFA group 
versus 100% in the surgical group.
Reports of non-randomised case series of RFA procedures showed that that RFA was effective in 
85% to 90% of the treated limbs with follow up periods varying from 2 to 5 years. Effectiveness 
was assessed with duplex ultrasound.34,42,43,44 
Laser ablation (EVLA)
Thermal laser energy is applied along the length of the vein by withdrawing the laser fiber. 
The temperature of the laser tip increases to 800˚C. Direct contact with the venous wall 
results in local destruction and may lead to (micro) perforation of the GSV and induces blood 
carbonization.34,45 patients also report the taste of burned blood during EVLA. 
There are three randomized controlled trials comparing EVLA with surgical stripping of the 
GSV. Darwood et al randomized 114 legs with a follow up period of 3 months.46 The primary 
outcomes were abolition of reflux (technical success) and improvement of quality of life (clinical 
success). Both treatments were equally effective in abolition of reflux. However, return to 
normal activity and work was significant quicker after EVLA. Rasmussen et al described similar 
results, with no important outcome differences between surgery and EVLA.47 Both treatments 
were performed with tumescent anaesthesia as an office based procedure. Postoperative 
pain and bruising was slightly higher in the conventional stripping group. Surprisingly they 
found no difference in return to normal activity and work between the two groups. Recently 
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Rasmussen et al published their 2 year follow up data.48 No significant differences in clinical 
or ultrasound recurrences were found between EVLA and surgery. Similar improvements were 
gained in clinical severity scores and quality of life scores in both treatments. Both studies 
had problems with recruiting patients, many patients expressed a preference for EVLA. The 
third RCT comparing EVLA with surgical stripping of the GSV is the largest study reported until 
now. Christenson et al randomized 200 patients with a follow up of 2 years.49 Abolition of 
GSV reflux, safety, improvement in QOL, and clinical severity score were similar. Also the time 
needed to return to work was equal with 7 days. The recanalization rate of symptomatic limbs 
was 3.2% in the EVLA group. There were no cases of neovascularisation in both groups as to be 
expected with mid-term follow up. Two randomized controlled trials focused on high ligation 
combined with stripping versus high ligation combined with EVLA.50,51 Both studies reported 
a significant difference in bruising and swelling in favour of the EVLA group. Disselhoff et al 
compared EVLA with cryostripping.52 Both procedures were similarly effective, but patients 
favoured EVLA because of less pain and postoperative morbidity, and quicker return to normal 
activity.
Table 2: Endovenous laser ablation (EVLA) versus conventional surgery (S)
  Darwood Rasmussen Christenson
legs (n) 114 137 204
follow up (months)  12  24  24
laser (nm) 810 nm 980 980 nm 
laser energy (J/cm)  65  74  76
time to resume work (days)  
laser ablation 4.4 7.0 6.9
surgical stripping  17 7.6 6.6
occlusion rates (duplex)  
laser ablation 88% 93%  93%
surgical stripping 92% 96% 100%
complications (EVLA/S)  
DVT 0/0 1/0  0/0
paresthesia 2/4 1/1  1/1
wound infection 1/3 0/1  0/0
hematoma – 3/5 12/5
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Several large case series with follow up periods varying from 1 to 4 year and at least 100 treated 
limbs have been reported.53-56 Success rates are as high as 100% post procedure and remain 
well above the 90% after midterm follow up. Desmyttere et al. presented a closure rate of 97% 
after treating 511 GSV with a follow up of 4 years.56
EVLA versus RFA
Recently several trials comparing the short term results of EVLA and RFA were published. 
Almeida et al concluded that RFA was significantly superior to EVLA in terms of post procedural 
recovery and quality of life.57 In the RECOVERY trial, a randomized, multicenter trial sponsored 
by VNUS, eighty seven patients were included and followed for 1 month. All scores referable to 
pain, hematoma, and tenderness were statistically lower in the RFA group at 48 hours, 1 week, 
and 2 weeks. The LARA trial is another randomized comparison between RFA and EVLA.58 
This trial had two cohorts, patients with bilateral GSV incompetence and those with unilateral 
GSV incompetence. In total 87 legs were treated in this study. Limbs in the bilateral group 
were treated with RFA in one leg and EVLA in the other. In the unilateral group limbs were 
randomised to RFA or EVLA. Occlusion rates were equal around 95%. In the bilateral group 
RFA resulted in significantly less pain and bruising compared to EVLA. In the unilateral group 
no significant differences were seen. The third RCT is by Shepherd et al.59 131 patients were 
enrolled and treated with RFA or EVLA under general anaesthesia. Primary outcome was mean 
post procedural pain over the first 3 days. Over the first 10 days pain scores and the use of 
analgesics were significant lower in the RFA group. However, these reductions could not be 
translated into faster recovery times. This study didn’t report occlusion rates. 
Complications of endovascular procedures
The most serious complication is DVT. Propagation of thrombus into the common femoral vein 
is thought to be the mechanism of DVT formation. The incidence of DVT is low with rates less 
than 1%.54-56,60,61 The risk of DVT is increased by performing the procedure under general or 
spinal anaesthesia and concomitant multiple stab phlebectomies.62 The total procedure time 
is then much longer and patients are not able to mobilize early, thus creating a higher risk of 
DVT. A push for early ambulation is imperative.
Initially, neural damage resulting in paresthesia and skin burns were reported relatively 
frequently, but the incidence decreased significantly.8,34,61,63 Procedural changes such as 
tumescent anaesthesia and introduction of the catheter at knee level instead of the ankle are 
responsible for this decrease. Skin burns are reported in approximately 0-2%.37,64 
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DISCUSSION
Conventional and cryo surgical treatment carries a risk of scarring, hematoma formation 
and wound infection. Other disadvantages are the use of general or spinal anaesthesia and 
therefore day care treatment. Endovenous thermal ablation techniques like RFA and EVLA are 
minimal invasive treatment options of the insufficient GSV. These procedures leave no scars 
and wound infections are seldom seen. Midterm follow up shows that endovascular treatment 
is at least as effective and durable as traditional high ligation and stripping of the GSV. The 
endovascular procedures are superior in terms of recovery and return to daily activities when 
compared to conventional surgery. In contrast to the conventional stripping, endovascular 
procedures are carried out under local anaesthesia in a outpatient setting, thereby reducing 
costs. Only one RCT compared EVLA with surgery using tumescent anaesthesia for both 
groups.49 Rasmussen et al found no significant advantage in terms of clinical outcome, severity 
scores or recurrence between both groups with short and midterm follow up. The outcome of 
this trial suggests that the short term advantages of the endovenous procedures could be due 
to the different anaesthesia techniques. Stripping and high ligation was well tolerated using 
tumescent anaesthesia. 
Randomized trials using RFA catheters report a significant better patient recovery phase after 
RFA compared to EVLA.57,58,65 Treatment related side effects such as pain and bruising are less 
after RFA treatment. The superior results in terms of patient recovery can be due to the fact 
that perforation of the GSV is rarely seen with RFA. 
It remains unclear what the clinical relevance is of these results. Two trials did not find a 
significant difference in return to normal activities58,66 and the third one reported no data on 
this subject.57 All of the three trials focussed on the short term, longer term clinical results are 
awaited. 
Neovascularisation is frequent after conventional surgery and is thought to be the primary 
cause for recurrent reflux and varicose vein.67 Pichot et al. performed duplex ultrasound 2 
years after RFA treatment. All of the 63 limbs treated did not show neovascularisation.68 Failure 
after surgery may be due to neovascularisation, double saphenous vein system, technical or 
tactical failure and incomplete procedure.69-71 There are several reasons accounting for the 
lower rates with endovenous techniques. An advantage of the endovenous techniques is the 
absence of the groin incision. It is believed that the surgical trauma is a potential trigger for 
neovascularisation. In addition, during the endovenous procedures the superficial epigastric 
vein remains patent. This means that the drainage of the abdominal wall is not disturbed, thus 
avoiding another trigger for neovasularisation.72
Neural damage is a common adverse effect of conventional stripping. Even after a short 
stripping, nerve injury occurs in about 7%. Both EVLA and RFA report significantly better 
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results with low rates of paresthesia. Skin burns can be easily avoided by applying tumescent 
fluid. Other adverse effects like wound infection are rare. 
CONCLUSION
All treatment modalities appear to be effective and safe with short and midterm follow up. 
Before considering endovenous treatments as first choice treatment, large high quality 
randomized trials with long term follow up are needed.
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INTRODUCTION
Superficial venous disease of the leg is common, disabling and costly and impacts negatively 
on patients’ quality of life.1 A UK cross sectional survey found a prevalence of trunk varicosities 
of more than 30%.2 Trunk varicosities originate from the great saphenous vein in almost 50%, 
the small saphenous vein in 30% and in 20% from both veins3 (Figure 1). 
We review the management of superficial venous incompetence of the leg focusing on the 
effectiveness of the procedures most commonly used and their complication rates. 
Figure 1: Venous anatomy of the leg
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SOURCES AND SELECTION CRITERIA
We performed a search of PubMed, Medline, Cochrane and Embase for the terms “varicose” or 
“saphenous” and extracted data from the most valid prospective cohort studies and available 
randomized controlled trials of the past 25 years. Efficacy of treatment was assessed by 
recurrence rate, quality of life, pain scores, return to daily activities and work. 
Numerous trials comparing treatment modalities have low numbers of included patients, 
absence of a clinically relevant primary outcome and involvement of the manufacturer. Several 
studies report problems with recruiting patients because many patients expressed a preference 
for endovenous procedures. Neither investigators nor patients were blinded to the treatment 
method in all randomized trials. Aforementioned problems are very likely to induce bias.
Who gets superficial venous incompetence?
A positive family history, increasing age and pregnancy are proven risk factors in developing 
superficial venous incompetence. Controversial risk factors are obesity, standing occupation 
and decreased mobility.4 There is no convincing evidence that venous incompetence is more 
common in women. 
How is superficial venous incompetence diagnosed?
Patients may complain of aching, itching, cramps, swelling and restless legs relieved by 
walking. Symptoms are mostly worse during the evening and night. Clinical signs vary from 
small reticular veins and varicosities, to oedema, eczema like skin changes and venous ulcers. 
The gold standard for diagnosis of superficial venous incompetence is a duplex ultrasound 
to identify valve incompetence. The sensitivity of duplex ultrasound for the great and small 
saphenous vein varies between 91% and 95%. The specificity varies between 95% and 100%.5 
Classification of venous disease
The CEAP classification is used for clinical description of venous disease in general and can be 
used for superficial venous incompetence.6 CEAP is an acronym for Clinical, Etiology, Anatomy, 
Pathophysiology. The ‘C’ is the most frequent used part of the classification to rate the clinical 
severity of venous disease. It ranges from C0 to C6 (Table 1). Etiology of superficial venous 
incompetence is often unknown. Anatomy and pathophysiology of venous disease can only 
be described after a venous duplex ultrasound.5
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Table 1: Clinical classification
class signs
C0 no visible signs of venous disease
C1 teleangiectases or reticular veins
C2 varicose veins
C3 oedema
C4 skin changes, lipodermatosclerosis
C5 healed ulcer
C6 active ulcer
To treat or not to treat?
There is no evidence that asymptomatic patients with venous disease need treatment or 
that ‘prophylactic treatment’ in these patients reduces the progression of venous disease. A 
good quality observational study concluded that venous disease will progress without further 
treatment.7 
Symptomatic patients with C1 to C6 disease can be treated to reduce symptoms.
Since patients may experience poor quality of life because of the way varicose veins look we 
argue that cosmesis is a valid reason for treatment.8,9 
What are the treatment options?
Treatment of great and small saphenous vein incompetence is either conservative with 
compression stockings or invasive. The objective is to reduce symptoms. Surgical treatment 
has consisted of high ligation and stripping of the great saphenous vein and high ligation 
for the small saphenous vein for decades. In recent years minimally invasive treatments such 
as endovenous thermo ablation and foam sclerotherapy have become popular. Suggested 
advantages of these approaches are reduced postoperative pain, faster recovery and improved 
cosmesis.
A good quality randomized trial with long term follow up recommended to perform a venous 
duplex ultrasound of the deep and superficial venous system prior to an intervention10. 
Treatment of the great or small saphenous vein is contra-indicated if there is an occlusion of 
the deep venous system identified with duplex ultrasound, because venous blood return is 
then only possible through the superficial venous system.
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Conservative management
Patients with symptoms but no wish for invasive interventions can be treated with short (below 
knee) class 2 compression stockings (20-30 mm Hg ankle pressure). Compression stockings 
improves both symptoms and venous hemodynamics. However, this benefit is limited to the 
period during which the stocking is worn. Stockings also have a poor patient compliance.11
Surgery for superficial venous incompetence
Short stripping of the great saphenous vein has been the treatment of choice for great 
saphenous vein incompetence in past decades. The saphenofemoral junction and its tributaries 
in the groin are ligated and divided followed by a strip of the great saphenous vein from groin 
to knee level. An alternative stripping method, cryostripping, has no benefits compared to 
conventional stripping.12
 
The incompetent small saphenous vein is only ligated and divided near the popliteal vein in the 
knee pit since stripping carries the risk of damaging the sural nerve. Nowadays a preoperative 
duplex ultrasound localisation of the small saphenous vein is performed prior to surgery. The 
venous system of the leg has a large residual capacity and will take over the function of the 
great or small saphenous vein. These surgical procedures are performed in day care and usually 
under general or spinal anaesthesia. Some specialized venous centers perform stripping using 
local anaesthesia (peri-venous tumescent anaesthesia) and peri-operative duplex ultrasound.
Recurrence after stripping of the great saphenous vein on duplex ultrasound is 13-29% after 5 
years in a randomized trial.13 A low evidence observational study suggests a recurrence rate of 
60% after more than 30 years.14 Recurrence after ligation of the small saphenous vein after 5 
years, confirmed by duplex ultrasound is 30%.15
 
Problems arising from superficial venous surgery are the single most common reason for 
litigation in the UK.16 Most settled claims result from a failure to warn patients for nerve 
damage. A short strip (groin to knee level) proposes a far less risk (8%) for saphenous nerve 
damage compared to the risk of a strip from groin to ankle level (40%).17 Incidence of deep 
vein thrombosis following conventional stripping confirmed by duplex ultrasound is about 
5%, mostly confined to the calf veins. About 2.1% of these patients are symptomatic.18 
Hematoma formation is common after stripping and wound infection occurs in about 10% 
and is responsible for delayed return to normal activity and work.19 Sural nerve damage after 
small saphenous vein ligation has an incidence of 2.1% and paresthesia rates of 1.7-34%.15
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ENDOVENOUS THERMO ABLATION FOR SUPERFICIAL VENOUS 
INCOMPETENCE
Radiofrequency ablation and endovenous laser ablation are minimally invasive catheter based 
procedures in which thermal energy is delivered into the vein wall. Thermal energy causes an 
inflammatory response resulting in fibrosis and closure of the vein (Figure 2).
The great or small saphenous vein is cannulated under duplex ultrasound guidance. A 
catheter is inserted and positioned near the saphenofemoral or saphenopopliteal junction. 
Local anaesthesia is administered as peri-venous tumescent anaesthesia. In this technique a 
large volume of local anaesthetic in saline solution is administered duplex ultrasound guided 
around the great or small saphenous vein which also prevents neural damage and skin burn 
due to cooling. These procedures do not require spinal or general anaesthesia and can be 
performed in an outpatient setting. The saphenofemoral and saphenopopliteal junction is, in 
contrast to the surgical procedure, not disconnected. Although this is a radical change from 
the conventional treatment, a small observational study concluded that there is no adverse 
impact on clinical outcome.20 
Endovenous laser and radiofrequency ablation
Endovenous laser ablation and conventional stripping are equally effective after two years.21 
Return to normal activity and work however was faster after endovenous laser ablation.22
When surgical stripping is performed duplex ultrasound guided with tumescent anaesthesia 
no difference was found in postoperative pain, recurrence rates, return to normal activity 
or work compared to endovenous laser ablation according to good randomised controlled 
trials.23,24
Endovenous radiofrequency ablation shows only slightly better short term results than 
conventional stripping, mainly on patient recovery.25,26
 A randomized trial sponsored by a manufacturer suggested that endovenous radiofrequency 
ablation is less painful than endovenous laser ablation and has a lower incidence of bruising.27 
Both procedures are equally effective for the treatment of the great saphenous vein in the long 
term, with a success rate of 95%.28
There are no studies comparing surgical and endovenous treatment of the small saphenous 
vein. Available data shows that endovenous laser ablation of the small saphenous is far more 
used than radiofrequency ablation. Success rates of endovenous thermo ablation of the small 
saphenous vein in large case series varies between 91-100%.15
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Figure 2: Endovenous ablation of the great saphenous vein by withdrawing the catheter.
 
Problems that may occur after an endovenous procedure
The incidence of deep vein thrombosis following endovenous procedures of the great 
saphenous vein is less than 1% and for the small saphenous vein between 1.3%-5.7%.15,29 
Early ambulation is essential. The risk of deep vein thrombosis is increased by performing 
the procedure under general or spinal anaesthesia and with concomitant multiple stab 
phlebectomies, as total procedure time is increased and patients are not able to mobilize 
early.30 Complications like neural damage and skin burns occur seldom because of the use of 
tumescent anaesthesia.31
FOAM
Foam sclerotherapy is an office based treatment. Sclerosing foam is injected through a cannula 
in the vein under duplex ultrasound guidance until the foam reaches the saphenofemoral or 
saphenopopliteal junction and vasospasm occurs. Compression therapy is immediately started 
after the procedure.
Foam sclerotherapy is popular because it is well tolerated, safe, easy to perform and can 
be repeated easily according to a large prospective study.32 In two small randomized trials, 
a slightly faster recovery after foam sclerotherapy compared to conventional surgery was 
observed.33,34
There are no studies comparing surgical and foam treatment of the small saphenous vein. 
Success rates of foam sclerotherapy of the small saphenous vein varies between 82-100% 
according to observational studies.15
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Bruising, tromboflebitis and skin pigmentation are frequent complications after foam therapy15. 
Trombo-embolic complication rates are low (0.4%).15,32 There have been some concerns about 
neurologic complications after foam sclerotherapy. Theoretically, micro-embolism can reach 
the systemic circulation through a patent foramen ovale. In a recent prospective case study of 
over 1250 treated legs, only five self limiting visual disturbances were seen. The risk of micro-
embolism causing serious adverse events was considered negligible.32
A good quality randomized trial, comparing stripping, endovenous laser ablation, endovenous 
radiofrequency ablation and foam sclerotherapy showed that the technical failure rate was 
highest after foam sclerotherapy. Endovenous radiofrequency ablation and foam sclerotherapy 
were associated with a faster recovery and less postoperative pain than laser ablation and 
stripping.35 
CONCLUSION
All treatment modalities appear to be effective and safe with short and mid term follow 
up. Before considering endovenous treatments as first choice treatment, large high quality 
randomized trials with long term follow up are needed.
SUMMARY POINTS
 – Venous disease should be classified according to the CEAP classification.
 – The gold standard for diagnosis of superficial venous incompetence is a duplex ultrasound.
 – The objective of therapy for superficial venous incompetence is to reduce symptoms.
 – All treatment modalities appear to be safe and effective with short and midterm follow up.
 – Endovenous procedures are associated with a faster postoperative recovery compared to 
conventional surgery.
 – A surgical strip under tumescent anaesthesia shows no differences on patient recovery 
compared to endovenous procedures.
QUESTIONS FOR FUTURE RESEARCH
 – Long term follow up of endovenous procedures.
 – Comparison between a modernized surgical strip with or without a ligation of the tributaries 
at the saphenofemoral junction.
 – Comparison of new minimally invasive catheter based techniques like Clarivein and Steam 
Vein Sclerosis to the current procedures. 
 – Comparison between compression stockings or no compression stockings after treatment.
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TIPS FOR NON SPECIALISTS
 – Use the ‘C’ of the CEAP classification when classifying venous disease.
 – In symptomatic patients, with no wish for operation, below knee stockings can be useful in 
the treatment of superficial venous incompetence.
 – Pre-treatment venous duplex ultrasound is recommended before proceeding with an 
intervention of the superficial venous system.
 – Always refer patients with an active or healed venous ulcer.
PATIENT’S STORY
I have stalled treatment of my varicose veins for years. I suffered from fatigue, swelling and 
restless legs almost every day. I hated the idea of an operation, but forgot to wear my stockings 
too often. Then my doctor proposed a laser treatment under local anesthesia. Finally I got on 
with it and went to the laser lab. The local anesthesia was not so bad, but I will never forget the 
awful taste of burned flesh during the laser treatment.
The first 8 days I suffered little pain but then it got really bad. I needed painkillers for another 
week. Two years after treatment my legs are so much better now and I am very glad I went on 
with this treatment.
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ABSTRACT
Purpose: This multicenter randomized clinical trial compared cryo stripping of the great 
saphenous vein (GSV) with conventional stripping.
Methods: The study randomized 494 patients with symptomatic (CEAP) clinical severity class 2 
to 4 to cryo stripping (n = 249) or conventional stripping (n = 245). The primary outcome was 
residual GSV 6 months after surgery measured by venous duplex ultrasound imaging. Secondary 
outcomes were quality of life, operation time, and postoperative neural damage. Duration of 
follow-up was 6 months. Quality of life was measured at 6 and 26 weeks postoperatively with 
the Aberdeen Varicose Vein Questionnaire (AVVQ) and Medical Outcomes Study Short-Form 36 
(SF-36) Health Survey.
Results: The two groups were well matched at baseline. The percentage of patients with residual 
GSV at 6 months (primary outcome) was 44% (102 of 230) in the cryo group and 15% (33 of 215) 
in the conventional group (difference 29%; 95% confidence interval [CI], 21%-37%, P < .001). 
Median operation time was significantly shorter in the cryo group (30 minutes) compared with 
the conventional group (39 minutes). Neural damage was 12% in both groups, and thus not 
significantly different. Scores on the subdomains of the SF-36 showed no significant change 
between the groups. The AVVQ after conventional stripping was 8.0, which was a better result 
than the 11.7 result after cryo stripping (difference 2.6 points; 95% CI, 1.0-4.2; P = .001, repeated 
measurements analysis of variance with adjustment for baseline scores).
Conclusions: Cryo stripping accounts for numerous procedural failures and hence residual 
GSV in patients. The AVVQ showed small but significantly better results for patients after a 
conventional stripping. Cryo stripping has no benefits over conventional stripping.
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INTRODUCTION
The high prevalence of venous disease of the leg accounts for enormous costs and loss of quality 
of life (QOL) worldwide.1-4 Venous disease is caused by venous incompetence of the superficial 
venous system, with or without venous incompetence of the deep or perforator vein system, or 
both.5-7 If we can reduce the number of patients with venous disease of the leg by improving 
the outcome of the current surgical therapy, it will reduce the costs and use of health care 
resources and improve QOL. Surgical treatment of the great saphenous vein (GSV) is indicated 
when there is valve incompetence at the saphenofemoral junction (SFJ) and GSV. Although 
endovenous laser and radiofrequency thermo ablation of the GSV are often used, the most 
commonly performed surgical treatment of the GSV in Europe is still conventional stripping. 
Cryo stripping of the GSV has been introduced in Europe as a faster and cosmetically better 
procedure compared with conventional stripping. Although there is insufficient evidence that 
cryo stripping can actually adequately strip the GSV, the technique is widespread throughout 
Europe.8-16 The outcomes in patients with symptomatic venous disease of the leg and duplex 
ultrasound (DU)–proven venous incompetence of the SFJ and GSV treated by conventional or 
cryo stripping were assessed in a multicenter, randomized clinical trial.
PATIENTS AND METHODS
This study was done accordance with the Consolidated Standards of Reporting Trials 
(CONSORT) statement.17,18 The study protocol was approved by the local ethics committee 
for every participating hospital. This trial was funded with local funds from the participating 
hospitals. There was no involvement of any company. The primary outcome was residual GSV 
6 months after surgery. Secondary outcomes were QOL, operation time, and postoperative 
neural damage. Patients had to be aged >18 years to be part of the study, and written informed 
consent was obtained from all participants. Patients were eligible for the trial if they had duplex-
proven venous incompetence of the SFJ and GSV and symptomatic venous disease of the leg in 
the CEAP clinical severity class of C2 to C4: C2, varicose veins, distinguished from reticular veins 
by a diameter of > 3 mm; C3, edema; C4, changes in skin and subcutaneous tissue secondary to 
chronic venous disease like pigmentation, eczema, lipodermatosclerosis or atrophy blanche.19 
All patients had primary etiology and reflux pathophysiology concerning their venous disease. 
Regarding anatomy, patients could have an incompetent deep venous system or incompetent 
perforating veins, which would not exclude them from the trial. Exclusion criteria were healed 
or active venous ulcer (C5 to 6), body mass index (BMI) > 40 kg/m2, recurrence of venous 
incompetence in the GSV, occlusion of the deep venous system, venous incompetence of the 
small saphenous vein, peripheral arterial disease as indicated by a non palpable pulse and 
an ABI < 0.9, already being part of the study with the contralateral leg, and the inability to 
understand the Dutch language. Patients were recruited from three district general hospitals. 
After confirmed diagnosis by venous DU imaging, patients were randomized to conventional 
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stripping or cryo stripping. Patient and surgeon were not blinded to the treatment. All surgeons 
who participated in this trial had to have performed at least five cryo stripping procedures to 
avoid the learning curve effect.
Venous DU imaging
An expert vascular technician did all DU scanning of the venous system. We used an ATL 
5000 scanner (Advanced Technology Laboratories, Bothell, Wash) with a 5- to 12-MHz linear 
array transducer. Venous incompetence of the GSV was defined when reflux times were > 0.5 
seconds in the full supine position. Venous incompetence of the perforating veins was defined 
when reflux times were > 0.35 seconds in half-supine position.20
Conventional stripping
The procedure was performed with spinal or general anesthesia. A 3-cm groin incision in the 
femoral skin crease was made. The common femoral vein (CFV) was dissected 1 cm cranial and 
distal to the GSV. All SFJ tributaries were ligated and divided. The GSV was ligated and divided, 
flush on the CFV. Conventional stripping was performed by passing a plastic stripper (Dormo-
strip, TapMed, Schauenburg, Germany) through the GSV from proximal to distal, to 8 cm below 
the knee. A 1-cm skin incision parallel to Langer’s lines was made over the tip of the plastic 
stripper. The end of the distal GSV was tied to the stripper, and a medium cone was attached 
to the plastic stripper. The distal incision was closed, and grade 2 stockings were applied. By 
pulling the stripper from distal to proximal, an antegrade stripping of the GSV was performed. 
The groin incision was closed with 4-0 subcutaneous suture (Vicryl, Ethilon, or Monocryl, 
Ethicon/Johnson & Johnson, Somerville, NJ).
Cryo stripping
This procedure started the same as the conventional stripping and was performed by passing 
a 3.5-mm diameter cryoprobe (Angiology Cryoprobe, Erbe, Germany) through the GSV from 
proximal to distal, to 8 cm below the knee. After freezing for 10 seconds at -85°C (expansion of 
liquid nitrous oxide in the cryoprobe), the tip of the probe freeze attaches to the GSV. Antegrade 
cryo stripping the GSV was performed by pulling back the probe. Grade 2 stockings were 
applied, and the groin incision was closed in the same fashion as in conventional stripping.
Postoperative protocol
The following data were entered in the patient case record form directly after the operation: 
total operating time; as measured from skin incision to skin closure. Length of stripped GSV. The 
length of residual GSV was calculated by subtracting measured stripped GSV from measured 
length on the leg (from the proximal to distal wound). Grading of the operative procedure as 
“no problems during procedure” or “problems during procedure” with a written explanation of 
the problems. If necessary, phlebectomy or sclerotherapy, or both, were performed a minimum 
of 2 to 3 months after surgery. Stab avulsions of varices were not performed during surgery. 
This policy has been in use in the participating hospitals for years because it was found that 
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most patients with varicose veins did not need extra interventions 2 to 3 months after stripping 
the GSV. This was also confirmed by van Neer et al.21 All patients were given subdermal low-
molecular weight heparin injections (2500 U, Dalteparin, Pfizer) preoperatively and for 1 day 
postoperatively. Patients had to wear the stockings continuously for the first 48 hours and 2 
weeks postoperatively only in daytime. They were instructed to mobilize as soon as possible. 
Only one leg at a time was operated on. This was normal policy in the participating hospitals. 
It is thought that this decreases morbidity and increases mobility. The second leg was treated, 
if needed, outside the scope of this trial after 6 months, which was the average time on the 
waiting list. So the included number of patients equals the number of legs in this study.
Follow-up
All patients were reviewed by an independent surgeon at the outpatient clinic at 2, 6, and 26 
weeks after treatment. Wound problems were assessed. Neural damage was examined with 
cotton sticks on the treated leg and compared with the untreated leg. Neural damage was 
graded as “numb feeling” or “hyperesthesia” of the leg. Venous DU imaging was performed 26 
weeks after surgical treatment. The result of the venous DU imaging was graded as a successful 
stripping or a non successful stripping. A successful stripping procedure was defined as a 
DU proven absent GSV without residual GSV. A non successful stripping procedure (primary 
outcome) was defined as residual GSV, subdivided in the following two categories:
1. Competent residual GSV was defined as DU-proven competence of a residual GSV.
2. Incompetent residual GSV was defined as DU-proven incompetence of a residual GSV.
Quality of life measurement
Quality of life was measured preoperatively and 6 and 26 weeks postoperatively using the 
Aberdeen Varicose Vein Questionnaire (AVVQ) and the Medical Outcomes Study Short-Form 36 
(SF-36) Health Survey. Garratt et al.22 designed the AVVQ in 1993 for measuring health-related 
QOL in patients with varicose veins. The AVVQ consists of 13 questions related to problems of 
venous disease such as pain and dysfunction, cosmesis, complications of venous disease, and 
extent of varicosity. The AVVQ results in a score from 0 to 100, with 0 representing the best 
score and 100 the worst. We used the validated Dutch AVVQ. Generic health status in patients 
with venous disease of the leg can be measured with the SF-36 survey.23 The 36 items result 
in eight domains after recoding related to physical and mental health and social functioning. 
The scores in the domains range from 0 (worst score) to 100 (best score), which is exact the 
opposite of the AVVQ score system.
Statistical analysis
Central randomization was performed using a computer-generated randomization list prepared 
by the trial statistician. Stratification was done according to center, venous incompetence 
of the deep venous system, and venous incompetence of the perforating vein system. To 
exclude a difference (cryo stripping minus conventional stripping) of 10% or more regarding 
the percentage of patients with residual GSV at 6 months, we calculated (alpha = 0.05, 80% 
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power) that 260 patients were needed in each arm of this non inferiority study. Percentages 
were compared using the chi2 test or the Fisher exact test. Continuous data were compared 
using the Mann-Whitney test. Center effects for the primary end point were investigated using 
multiple logistic regression analysis. A repeated measurements analysis of variance (ANOVA; 
SAS proc mixed) was used to evaluate changes from baseline of the various domains and 
scores of the SF-36 and AVVQ with adjustment for baseline value. Patients were analyzed in 
their allocated group (intention to treat principle). A two-sided P = .05 was considered the limit 
of significance in all analyses.
RESULTS
The study randomized 536 patients: 268 to cryo stripping and 268 to conventional stripping. 
After randomization, 42 patients were excluded: 25 went to another hospital because of a 
shorter waiting list, 16 cancelled their operation for personal reasons, and one patient had 
a small transient ischemic attack, after which he cancelled his operation. This resulted in 249 
patients in the cryo strip group and 245 patients in the conventional strip group (Figure 1). 
Figure 1: Flow diagram shows inclusion of trial patients
Randomized to Cryo-Strip (n = 268) Randomized to Conventional strip (n = 268)
No operation (n = 19) No operation (n = 23)
Operation (n = 249) Operation (n = 245)
Analyzed for primary outcome (n = 230) Analysed for primary outcome (n = 215)
Randomized (n = 536)
Eligible patients (n = 536)
Patient demographics are reported in Table 1. There were 121 men (25%) and 373 women 
(75%), with a mean age of 55 (SD 14.1). Mean BMI was 25.4 (SD 4.2) kg/m2. Comorbidity included 
hypertension, 25 patients; diabetes mellitus, 6; pulmonary disease, 17; cerebrovascular accident 
or transient ischemic attack, 5; and cardiac disease, 11. The full CEAP score for both groups is 
reported in Table 2. As a result of stratification, both groups had similar numbers of patients 
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with an incompetent deep venous system or incompetent perforating vein system. Nine 
patients underwent conventional stripping instead of cryo stripping because on six occasions 
no experienced surgeon was available to perform cryo stripping and on three occasions the 
cryo stripping device was being used in another operating room. One patient underwent 
cryo stripping instead of conventional stripping because of a miscommunication. A total of 
19 patients in the cryo strip group and 30 patients in the conventional strip group were lost 
to follow-up for the primary outcome. A total of 38 patients were contacted several times by 
mail and telephone but refused to visit the outpatient clinic. The other 11 patients had given 
a wrong address or telephone number and could not be traced. In the cryo strip group, 230 
patients could be analyzed for primary outcome. In the conventional strip group, 215 patients 
could be analyzed for primary outcome. The number of operations performed in the different 
hospitals was as follows: 374 in Sint Franciscus Hospital, 111 in Albert Schweitzer Hospital, and 
nine in Twee Steden Hospital.
Table 1: Demographics of included patients in the cryo strip group compared with the conventional 
strip group
Variable Cryo Conventional
Patients, No. 249 245
Age, mean (SD), y 56 (14.3) 54 (14.0)
Male, No. (%) 52 (21) 70 (29)
Female, No. (%) 197 (79) 175 (71)
Body mass indes, mean (SD) kg/m2 25.1 (4.2) 25.8 (4.3)
Hypertension, No. 10 15
Diabetes mellitus, No. 3 3
Pulmonary disease, No. 9 8
CVA or TIA, No. 2 3
Cardiac disease, No. 5 6
CVA, Cerebrovascular accident; TIA, transient ischemic attack.
Primary outcome
We found a significant difference of residual GSV between cryo stripping and conventional 
stripping in this study. The percentage of patients with residual GSV at 6 months was 44% 
(102 of 230) in the cryo strip group and 15% (33 of 215) in the conventional strip group 
(difference 29%; 95% confidence interval [CI], 21%-37%, P = .001). Competent residual GSV 
was found in 47 patients (20%) after cryo stripping and in 15 (7%) after conventional stripping. 
Incompetent residual GSV was found in 55 patients (24%) after cryo stripping and in 18 (8%) 
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after conventional stripping. Multiple logistic regression analysis showed that this difference 
was not affected by center.
Secondary outcomes
Recurrence at the SFJ is a known phenomenon.24 The stripping technique in this study had 
no influence on the incidence, because groin incision and dissection at the SFJ were identical 
in both techniques. There was no significant difference between the stripping techniques 
in recurrence at the SFJ: 42 patients (18%) after cryo stripping and 37 patients (17%) after 
conventional stripping. Operation time was significantly different between cryo stripping 
and conventional stripping. Median operation time was 30 minutes (range, 10-120 min) in the 
cryo strip group and 39 minutes (range 15-100 min) in the conventional strip group (P = .001). 
Significantly more problems during operation were encountered in the cryo strip group. Cryo 
stripping was problematic in 84 patients (34%), and conventional stripping was problematic 
in 28 patients (11%; P =.001). The most common problems were perforation of the GSV by the 
rigid cryoprobe and detachment of the GSV from the probe during stripping. Neural damage 
occurred in 31 patients (12%) after cryo stripping and in 30 patients (12%) after conventional 
stripping, which was not a statistically significant difference (P = .787).
Table 2: Number of patients by treatment group according to the CEAP classification
Conventional stripping, No.
E A P
C Primary Secondary Congenital Superficial Deep Perforating Reflux Obstuction
2 208 0 0 208 51 66 208 0
3  18 0 0  18 10 15  18 0
4  19 0 0  19 15 17  19 0
 Cryostripping, No.
2 211 0 0 211 51 65 211 0
3  18 0 0  18 11 17  18 0
4  20 0 0  20 17 19  20 0
Quality of life
The AVVQ and SF-36 questionnaires were returned by 419 patients (85%) preoperatively, 334 
(67%) at 6 weeks postoperatively, and 265 (53%) at 26 weeks postoperatively. The AVVQ change 
for baseline scores were compared for randomized treatments using repeated measurements 
ANOVA with adjustment for baseline scores (Table 3). All changes from baseline scores within 
groups were significantly lower at both time intervals. At 26 weeks the adjusted baseline score 
difference between groups was 2.6 points in favor of conventional stripping (95% CI, 1.0-4.2; 
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P = .001). In the SF-36 (Table 4), significant changes of baseline score were found after cryo 
stripping and conventional stripping for the domains of physical functioning and bodily pain. 
Table 3: Aberdeen Varicose Vein Questionnaire score change by treatment group 
AVVQ score (standard error)
Time Cryo Conventional Pa
Baseline 18.3 (0.57) 16.4 (0.59)
6 weeks 13.5 (0.57) 12.5 (0.60)
26 weeks 11.7 (0.60) 8.0 (0.65) .001
Pb <.001 <.001
AVVQ, Aberdeen Varicose Vein Questionnaire.
a Score at 26 weeks comparing AVVQ scores for cryo stripping with conventional stripping using repeated measurements analysis 
of variance with adjustment for baseline scores.
b Score at 26 weeks compared with score ate baseline within group.
Table 4: Medical Outcomes Study Short-Form 36 Health Survey score change by treatment group
Groupa PF RP BP GH VT SF RE MH
Cryo
Baseline 78.5 72.3 68.5 272.6 66.0 85.7 86.2 58.2
6 weeks 82.5 78.0 78.1 72.5 65.3 85.1 84.5 58.2
26 weeks 85.8 84.1 81.7 72.2 69.8 87.0 87.8 57.8
Pb <.001 <.001 <.001 .71 .01 .58 .80 .66
Conventional
Baseline 80.9 79.7 73.3 74.7 69.3 88.2 87.1 59.9
6 weeks 83.7 79.8 78.6 72.9 67.8 88.2 88.0 58.6
26 weeks 84.5 83.2 82.2 72.3 69.1 89.2 89.4 58.1
Pb .02 0.19 <.001 .07 .96 .58 .47 .08
PF, Physical functioning; RP, role limit (physical problems); GH, general health perception; VT, vitality; SF, social functioning; RE, role 
limit (emotional problems); MH, mental health.
a No significant differences were found between both groups at 6 and 26 weeks.
b Statistical significance was set at P < .05. 
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Significant changes of baseline score were only found after cryo stripping for the domains of 
role limitations due to physical problems and vitality. The domains of general health, social 
functioning, role limitations due to emotional problems, and mental health did not significantly 
change from baseline scores in either group. For none of the domains did the mean changes 
differ between both groups. This applies to both the 6 weeks and 26 weeks results.
Complications
Seven patients presented with complications, of which five were in the cryo strip group:
 – A small groin hemorrhage required operative exploration.
 – A postoperative neurapraxia of the peroneal nerve developed, which healed after 4 months 
with no clinical complaints.
 – A deep venous leg thrombosis developed in an operated leg, confirmed by venous DU 
imaging, 2 weeks after surgery. This patient was treated with warfarin for 6 months, after 
which there were no clinical complaint, and DU imaging showed an open, although 
incompetent deep system.
 – Persistent lymph leakage from the groin incision required operative exploration, after 
which there were no clinical complaints.
 – In one patient the surgeon mistook the CFV for the GSV and had thus divided the CFV. 
An expert vascular surgeon anastomosed the CFV, and the GSV was not stripped. After 
receiving warfarin for 6 months, the patient had no clinical complaints and an open, 
although incompetent, deep venous system. One year later, cryo stripping of the GSV was 
performed.
Two complications occurred in the conventional strip group:
 – A clamp on the GSV was pulled which caused a lesion of the CFV. The CFV was sutured using 
a patch.
 – A small myocardial infarction occurred that required no invasive interventions. The patient 
was discharged from the cardiology ward after 2 days.
Secondary phlebectomy or sclerotherapy for non-truncal varicosities was performed in 108 
patients (22%) after 2 to 3 months. There was an even distribution among the groups: cryo 
stripping, 52 patients (10.5%); conventional stripping, 56 patients (11.3%).
DISCUSSION
Primary outcome
When the primary outcome was examined, cryo stripping performed significantly worse than 
conventional stripping in terms of residual GSV. The participating surgeons graded the cryo 
stripping in 34% of the cases as a procedure with minor or major problems compared with 
11% who had conventional stripping. Although every participating surgeon had performed at 
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least five cryo strip operations to avoid the learning curve effect, it could be argued that this 
number was too small. There was an indication of a learning curve effect for one of the centers 
in the cryo strip group. For that center, the first 25 patients who had cryo strip procedures 
did somewhat worse than later patients (P = .048). However, comparing the percentages of 
residual disease at 6 months after disregarding the first 25 patients within each center and 
treatment group gave similar results as for the total group: 42% for cryo stripping versus 15% 
for conventional stripping (P =.001). The cryo stripping technique is substantially different 
from a conventional technique. Instead of a flexible plastic stripper, a rigid metal probe has to 
be advanced in retrograde fashion through the GSV. Although the cryoprobe provides some 
tactile feedback to the surgeon, it is much less compared with a plastic stripper. When the 
probe cannot easily be pushed further through the GSV, it is difficult to differentiate between a 
competent valve and the wall of the GSV. This is probably the cause of many procedural failures 
during cryo stripping where perforation through the GSV had occurred. Another problem was 
caused during the initial freezing of the distal GSV. Although the cryo probe has to be pulled 
vigorously to break the frozen GSV, too much force can detach the probe from the GSV, which 
results in a partially stripped GSV. It could be argued that retrograde cryo stripping could 
decrease the procedural problems, but the possible cosmetic advantage is then lost because 
of the need for a distal incision under the knee. Schouten et al16 also reported more residual 
GSV after cryo stripping, with a mean length of stripped GSV of 27 cm after cryo stripping 
compared with 40 cm after conventional stripping. This was because an alternative cryo strip 
technique was used in this study; the GSV was stripped from the groin to above the knee to 
avoid possible difficult guiding of the cryo probe past the knee. Although Stötter et al25 also 
found residual GSV after cryo stripping (10%), the low number of patients (n = 20) randomized 
in the cryo stripping arm makes a conclusion of that study difficult. Menyhei et al26 found 
major procedural problems in the cryo strip group in six of the 79 included patients (8%). 
These patients were further excluded from the trial. The primary outcome of that study was 
QOL; therefore, no venous DU follow-up was described. Regarding recurrence at the SFJ, no 
significant difference between cryo stripping and conventional stripping was found. This was 
expected because the operation technique of groin exploration was the same in both groups. 
This recurrence rate is similar to that reported by de Maeseneer.27
Operation time
Median operation time was significantly shorter in the cryo strip group (30 minutes), which 
was expected because a distal incision at the knee is not needed. The outliers in the operation 
time range were caused by complications in both groups. It took 120 minutes in the cryo strip 
group and 100 minutes in the conventional group to repair the CFV. Stötter et al25 reported a 
shorter mean operation time of 19 minutes, whereas Schouten et al.16 reported an operation 
time of 18 minutes. A possible reason for these faster operation times could be that all the cryo 
stripping procedures were performed by a standard team of two surgeons, as described by 
Schouten et al. A faster operation time makes it possible to treat more patients in a given time 
and shorten the long waiting lists that exist in the Netherlands for GSV stripping. Although this 
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is a positive finding of the cryo strip technique, it is overshadowed by the high incidence of 
postoperative residual GSV.
Neural damage
No significant difference in postoperative neural damage between cryo stripping and 
conventional stripping were expected or found. The incidence of neural damage at 26 weeks 
was similar as that reported by Tennant et al.28 and Critchley et al.29 Most patients had 
a hyperesthesia or numb feeling of the medial aspect of the upper or lower leg, which can 
be explained by a lesion or neurapraxia of the saphenous nerve. Because both techniques 
performed a short stripping of the GSV, no difference was expected.
Complications
Of the seven complications, two major complications were a direct result of the surgical 
stripping technique. In one patient in the cryo strip group with a BMI of 18 kg/m2, a transection 
of the CFV was made, caused by a surgeon who misidentified the GSV. The misidentification 
occurred because the GSV was extremely superficial and had such a small diameter that it was 
mistaken for an accessory vein. When dissecting to the deep venous system, the CFV had the 
diameter of a regular GSV. This complication could have been prevented if the surgeon had 
anticipated a small diameter GSV in this thin patient and had tried to identify the SFJ.30 In 
another patient in the conventional strip group, the CFV was torn when a clamp on the GSV 
was accidentally pulled. It is not certain if this complication could have been prevented. There 
is always a small complication risk during surgical procedures, and one can only try to decrease 
this risk by working meticulously. Accidental deep vein lesions during superficial vein surgery 
have been described before in the literature, but mostly as case reports.
Quality of life
Patients in both groups had significantly better AVVQ scores postoperatively. Patients in the 
conventional strip group scored significantly better than those in the cryo strip group. The 
AVVQ is a health-related QOL questionnaire that has been proven to measure small changes 
in QOL before and after treatment. The reason that conventional stripping scored better than 
cryo stripping could be the high incidence of residual GSV after cryo stripping. Although the 
small change in AVVQ score (2.6) between both groups is numerically significant, one could 
argue if this has any clinical relevance on a total score of 100. A long term follow-up study of 
all patients with venous DU imaging, AVVQ, and SF-36 is now being conducted to answer this 
question. Smith et al2 also found minute AVVQ changes before (18.8) and after (14.1) surgical 
treatment. The AVVQ scores can significantly increase when patients with healed or active 
venous ulcers (C5 and C6) are included, because these AVVQ-related items account for much 
higher scores. Because this study excluded patients with clinical severity class C5 and C6, one 
can expect to have patients with lower preoperative AVVQ scores and hence smaller changes 
postoperatively. Possibly two new health-related QOL questionnaires could be designed. One 
questionnaire needs to emphasize items specifically related to patients with clinical severity 
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class 1 to 4. Most patients with venous disease would be appropriate for this questionnaire. 
The other questionnaire would need to emphasize items specifically for severity class 5 to 6, 
because pain and socially related items carry more weight in these patients. This would have 
the benefit that QOL scores in patients with C1 to 4 are not diminished by items related to C5 to 
C6, such as in the AVVQ. No significant changes were found in the SF-36 results postoperatively 
in any of the eight domains between the cryo strip group and the conventional strip group. 
Studies have shown that a generic QOL questionnaire like the SF-36 poorly reflects the effects 
of chronic venous disease. This may well explain that no difference was found between the 
groups. There were significantly better scores postoperatively in the domains of physical 
functioning and bodily pain in both groups. These results were similar to those reported 
by Menyhei et al,26 in which QOL was the primary end point It was to be expected that the 
domains of physical functioning and bodily pain would have better scores postoperatively 
because most patients have fewer problems from swollen legs, restless legs, heavy feeling, 
and pain in the legs after their operation. The cryo strip group had significantly better scores 
postoperatively in the domains of vitality and role limitation because of physical problems (RP). 
There is no ready explanation for these higher scores except perhaps the lower baseline scores 
in the cryo strip group compared with the conventional strip group. Menyhei et al.26 found 
no significant difference for the RP domain but a significant change for the vitality domain, 
which was also unexplained. In both AVVQ and SF-36 pain was found to be significantly less 26 
weeks after stripping of the GSV, regardless of which strip was used. Future use of generic QOL 
questionnaires like the SF-36 for measuring the often-small changes in QOL after (surgical) 
therapy in patients with clinical severity class 1 to 4 should be dissuaded.
CONCLUSIONS
Cryo stripping with a rigid cryoprobe accounts for numerous procedural failures and hence 
residual GSV in patients. Health-related QOL measured by the AVVQ showed small but 
significantly better results for patients after conventional stripping. Cryo stripping has no 
benefits over conventional stripping.
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INTRODUCTION
The treatment of incompetent perforating veins (ICPV) in combination with superficial 
venous system treatment is perceived to be the best treatment for patients with chronic 
venous leg ulceration (C6 according to the Clinical-Etiology-Anatomy-Pathophysiology [CEAP] 
classification).1 Improvements in surgical techniques could bring down costs and result in a 
higher patient satisfaction. Dissection of ICPV can be performed with subfascial endoscopic 
perforating vein surgery (SEPS). First performed by Dr. G. Hauer in Germany, SEPS is the most 
common used surgical technique worldwide but has is its limitations.2 SEPS can show poor 
results because of a challenging learning curve but even in experienced hands it still has 
its limitation. The narrow confines due to tapering at the ankle have been proven to be the 
most important limitation. Clinical important ICPV cannot be reached. Wittens et al showed 
the consequences of leaving important perforating veins and stressed that they should all 
be treated.3 Other limitations of SEPS are mentioned in the previous chapter. The need to 
overcome these problems has resulted in alternative minimal invasive techniques. Although 
few reports and cohort studies have been published about these alternative techniques, most 
of these studies are done as feasibility studies. A randomized controlled trial on any of these 
techniques has never been performed, which is essential for selecting one of these methods 
on evidence based facts.
Sclerotherapy of ICPV
This technique, also known as ultrasound-guided sclerotherapy (USGS) of ICPV, was first 
described by Thibault.4 Under local anaesthesia the ICPV are duplex guided entered with a 
needle. After venous blood is aspired, a sclerosant is injected into the vein. After the treatment 
patients get a compressive bandage or stockings around the limb. In a cohort study, Masuda 
et al describes their technique and results with USGS on a group of patients with isolated 
ICPV a patent deep and superficial system5. In a period of 4 years, 80 limbs in 68 patients were 
treated with USGS. Perforator vein incompetence was defined as presence of outward flow or 
bidirectional flow. Retrograde flow lasting more than 0.5 seconds was used as a cut-off value 
for defining incompetence. Before USGS all significant perforators were identified by duplex 
scanning. After sterile preparation of the leg a 25-gauge needle was duplex guided introduced 
into the ICPV. After venous blood aspiration, 1.5 ml sodium morrhuate was injected in the 
ICPV. Extra care was taken to prevent arterial damage by injecting the sclerosant just after 
the ICPV has exit the fascia. If the sclerosant was injected extraluminal or if there was high 
resistance the procedure was aborted. All patients continued with compression bandage one 
week after USGS and were then instructed to use their elastic stockings. Follow up consisted of 
an interview, clinical examination and duplex scanning at 1, 3 and 6 months intervals. Clinical 
outcomes were measured by using the Venous Clinical Severity Score (VCSS) and Venous 
Disability Score (VDS) and CEAP classification.
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The results showed an initial success percentage of 98%. Mean ICPV size was 3.7 mm and the 
number of treated ICPV ranged from 1 to 8 per patient. The following distribution of clinical 
status according to CEAP was found: C1: 0 / C2: 6.25% / C3: 17.5% / C4: 28.75% / C5: 1.25% / 
C6: 46.25%.
Follow up duplex scanning after one month was performed on 57 limbs. In 19 limbs (33.3%) 
new or recurrent ICPV were found, 12 of these were patients with C6. All VCSS and VDS scores 
were lower post USGS, but only in patients with C4 and C6 these results were statistically 
significant. Group size of C2 and C5 was too small to investigate. 
Ulcer healing rate was 67.6% with one USGS treatment. Ulcer recurrence rate was 32.4%. 
Average time for ulcer healing was 35.6 days. 
Complications were skin necrosis in one patient, because of intra arterial injecting of the 
sclerosant. Skin necrosis healed after 4 months.
There is only one very small study mentioning ICPV treatment with ultrasound guided 
sclerotherapy using foam.6 A lot of data show the superiority of foam versus liquid sclerotherapy 
in other veins, especially the GSV or SSV. It can be theorized that if ICPV will be treated with 
foam the results might improve significantly. Results from future trials have to be awaited. 
Cryo treatment of ICPV
This technique, also known as Cryo Perforator Surgery (CPS) was first described by Klem and 
Wittens in 2008.7 CPS makes use of a cryo device (Erbe) and a small cryoprobe (Figure 1). In a 
feasibility study 15 patients with 28 ICPV were treated with CPS. All patients had isolated ICPV 
and no incompetent deep system. 
Figure 1
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The superficial system had already been treated or was competent. Because the effects of CPS 
in the proximity of (healed) ulcers were uncertain, avoiding all risks, patients with C5 and C6 
(CEAP classification) venous disease were not enrolled in this study. Before treatment all ICPV 
were ink-marked on the skin using duplex scanning. Incompetence was defined when reflux 
times exceeded 0.35 seconds.
CPS was performed under local anaesthesia (lidocaine 1%). The ICPV were approached 
percutaneously with a 14 gauge cannula at the fascia defect under duplex scanning guidance 
(Figure 2). The cannula could be placed intraluminal or extraluminal in small diameter ICPV. 
The cryoprobe with a diameter of 1.6 mm was introduced through the cannula and frozen for 
15 seconds at -89 degrees Celsius (Liquid dinitrous-oxide, N2O). 
Figure 2
During the freezing, an ice cone was formed at the tip of the cryoprobe (Figure 3) The ICPV 
was freeze-attached to the ice cone, and dissection was obtained by withdrawing the probe 
vigorously. 
Figure 3
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Treatment was considered successful perioperative when ICPV showed no signs of flow despite 
augmentation on the duplex scan. A compression bandage was applied in all patients and they 
were discharged 1 hour after the operation. Follow-up duplex scans were performed 2, 4, and 
20 weeks after treatment. Total follow-up for all patients was 20 weeks. Patients consisted of 
3 men and 12 women with a median age of 55 years (range, 22-76 years) and complaints of 
chronic venous disease. There was no comorbidity.
Preoperative duplex scanning showed 28 ICPV in 15 patients. All ICPV were treated with CPS. 
Distribution of the ICPV was as follows: posterior tibial perforator, 12; paratibial perforator, 
11; intergemellar perforator, 1; lateral leg perforator, 4 (range, 1-5 per patient). The diameter 
(median) of the fascia defect was 2.8 mm (range, 1.8-6.8 mm) and depth (median) of the fascia 
defect was 10.4 mm (range, 3.7-22.0 mm). Perioperative duplex showed no signs of flow in 
all treated ICPV. Follow-up duplex after 2, 4, and 20 weeks showed successful treatment in 12 
perforating veins (43%).
Distribution of perforating veins in successful treatment: posterior tibial perforator, 4; Paratibial 
perforator, 6; intergemellar perforator, 0; lateral leg perforator, 2.
There were no perioperative complications. Five patients developed a small haematoma on 
the leg, which healed within 2 weeks. All patients completed the follow-up period.
Radiofrequency ablation of ICPV
The most common used method is the radiofrequency (RF) ablation technique with the 
device from VNUS Medical technologies, San Jose, California. RF ablation is a thermal ablation 
technique in which delivery of heat is controlled by a RF generator which measures power, 
impedance, temperature and elapsed time so that precise temperature control is obtained. 
For ICPV treatment there is the RF system ClosureRFS and ClosurePLEX catheters. Whitely et al 
was the first to publish the results of RF ablation in ICPV.8 In an overview article of RF ablation 
techniques, Roth describes in short the technique for RF ablation of ICPV with use of VNUS 
catheters 9. The technique requires a more detailed duplex scanning because perforating veins 
are not linear in orientation like the superficial veins and are more curvilinear and angulated 
throughout their course. After visualisation the ICPV were ink-marked on the skin. After sterile 
preparation the skin was locally infiltrated with lidocaine 1%. Through a small skin incision the 
ICPV were accessed directly with a rigid RF stylet (ClosureRFS) (Figure 4) Another technique 
make use of a Seldinger technique with a 21 gauge needle and guide wire to access the 
ICPV after which a flexible ClosurePLEX catheter (Figure 5) was used to perform RF ablation. 
Either catheter was positioned at the fascia level. When the stylet was removed, the tip of 
the ClosureRFS catheter was at the right position, between 5-10 mm from the fascia. The 
ClosurePLEX had to be pulled back 5-10 mm. After tumescent fluid infiltration above and 
below the catheter the patient was positioned in Trendelenburg. RF ablation temperature 
was 85-90 degrees Celsius for 5 minutes. During the first 4 minutes the catheter was rotated 
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every minute, 12, 6, 3 and 9 o’clock positions. In the last minute the catheter was pulled back 
1-10 mm. When RF ablation was performed the deep venous system and arterial system were 
assessed for patency and the catheters were removed. Patients had stockings applied after 
the treatment for minimal 3 to 4 days. Patients could resume daily activities immediately and 
follow up duplex scan was performed after 72 hours. 
Figure 4
Figure 5
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In a large cohort study, Peden and Lumsden describe RF ablation of 770 ICPV in 506 limbs.10 
From this article it is not clear what the distribution of C (according to the CEAP-classification) 
among the patients was. All of the patients had C4-C6 venous disease. The authors claim a 
success rate of 79% after 1 year and 76% after 2 years. There was no information about the 
amount of patients who were lost to follow-up. No information was given about the definition 
used for incompetence of ICPV or procedural complications.
LASER ablation of ICPV
Thermal ablation of ICPV with use of LASER has been first described by Proebstle et al 11. In 
this feasibility study 67 ICPV in 60 patients were treated with LASER (Figure 6). Patients with 
all stages of chronic venous insufficiency and duplex proven ICPV were included in the study. 
Technique is as follows: the ICPV was accessed was duplex guided punctured just above the 
fascia plane with an 18-gauge cannula. 
Figure 6
The catheter was then advanced 3-5 mm subfascial, with a distance of at least 10 mm from the 
deep system. After placement of the LASER fiber, local anaesthesia was given (prilocaine 0.5%). 
The fiber was connected to a 940 nm diode LASER or to a 1320 nm Nd:YAG LASER. The desired 
location of the tip was again ascertained by duplex scanning. During an initial pilot phase 
optimal power of the LASER was investigated, ranging from 5 to 30 Watt. LASER energy was 
given in pulsed fashion instead of continuous beam. For the treatment, 3 pulses were given; 
one below fascia level, one at the fascia level and one above fascia level. Every pulse had an 
energy of approximately 60 joule. At the end of the LASER treatment a bandage was applied for 
48 hours after which the patient should wear their elastic compression stockings. Most treated 
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patients had C2 venous disease and only one patient had C6. Median diameter of all ICPV was 
3.3 mm (range 1.1-8.0 mm) In the pilot phase, the use of a low LASER power (5-8 Watt) resulted 
in occlusion of 27 perforators. On day 1 post treatment all but one ICPV were occluded. There 
was shrinkage of 36% of all ICPV, but this was not statistically significant. Using high power 
LASER (940 nm; 30 Watt, 1320 nm; 10 Watt) all ICPV were occluded 1 day post treatment, with 
a significant shrinkage of 69% in the 1320 nm LASER group and a non-significant shrinkage 
in the 940 nm LASER group. Taking together all ICPV treated either with 940 nm or 1320 nm, 
the mean diameter reduction was 79 ± 33%. This diameter reduction was achieved using a 
median LASER power of 220 joule. The 3 months follow up of 16 patients (27%) showed no 
significant diameter change compared to 1 day postoperative. The most common side effects 
were ecchymosis (50%), paresthesia (16%) and hyperpigmentation (8%). There were no major 
complications.
Coil embolisation of ICPV
Van Dijk and Wittens investigate the feasibility of ultrasound-guided percutaneous coil 
embolisation of incompetent perforating veins as minimally invasive treatment for venous 
ulcers and recurrent varicosities in the lower leg.12 In 15 patients (six women, nine men; mean 
age, 50 years), 18 incompetent perforating veins in the lower leg were treated by ultrasound-
guided percutaneous placement of embolisation coils (Figure 7). Successful vein occlusion 
with one or more coils was achieved in 12 of the 18 veins (technical success rate, 67%). Clinical 
symptoms improved in only three of the 15 patients (clinical success rate, 20%). 
Figure 7
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During follow-up (2-12 months), recanalization of coil embolized veins occurred in nine of 
the 12 initially occluded veins. They concluded that percutaneous ultrasound-guided coil 
embolisation does not appear to be as effective as subfascial endoscopic perforator surgery in 
the treatment of incompetent perforator veins.
Duplex-Directed Interruption of Incompetent Perforator Veins (DDICPV)
In an effort to minimize wound complications, circumvent difficult anatomy, and simplify 
the procedure, Seiwert and Comerota introduced a duplex-directed technique to interrupt 
ICPV using phlebectomy hooks, which is inexpensive and minimally invasive.13 Twenty-three 
extremities with ICPV were treated in 18 patients. Eighteen limbs had end-stage venous 
insufficiency (CEAP classes 4, 5, and 6). Two patients had undergone previous modified 
Linton procedures and one had prior subfascial endoscopic perforator surgery (SEPS). ICPV 
in the affected region were identified by duplex ultrasound. A Muller phlebectomy hook was 
introduced through a 1.5 mm incision placed in regions of healthy skin. Duplex ultrasound 
imaging allows the operator to engage the ICPV by the remote subcutaneous entry of the 
phlebectomy hook. ICPV interruption/avulsion is viewed real-time. Successful interruption is 
often accompanied by a short period of brisk bleeding easily controlled with direct pressure 
and cessation of flow in the perforator. Application of a compression dressing completed the 
procedure. ICPV disruption was confirmed in all limbs intraoperatively. Seventeen patients 
were discharged on the day of surgery. There were no wound complications and postoperative 
pain was minimal. Follow-up ranged from 3 to 52 months. Twelve limbs had ulcers healed and 
all patients noted significant improvement of leg symptoms. Two ulcers recurred within 24 
months; one had either a missed or second ICPV, which was treated with DDICPV, and the other 
had severe deep venous reflux and was treated with compression after finding no additional 
ICPV. They concluded that DDICPV is a simple, inexpensive, and minimally invasive technique 
for interruption of ICPV under direct vision that has a short learning curve, is well tolerated by 
patients, and is effective in treating ICPV
DISCUSSION
When comparing these 6 alternatives for SEPS, one should notice the lack of randomized 
controlled trials. Group size, follow up, patient inclusion and definition of incompetence 
differed between the studies of these alternative techniques. Therefore we cannot recommend 
one of these techniques above another. 
Ultrasound guided sclerotherapy showed good initial results in a highly selective patient 
group but after one month 32.4% of the patients had recurrence. Initial ulcer healing after 
USGS was 67.6% with a recurrence rate of 32.4%. USGS requires intraluminal access of the 
ICPV that makes it difficult for the treatment of smaller ICPV. In follow up patients showed a 
decrease in their VCSS and VDS scores. USGS with foam might improve the results, but up till 
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now the results are poor. The only reason why these poor results are accepted is that it can 
be repeated and it is cheap. But we should select the best therapy for the patient and not the 
cheapest. 
Cryo perforator surgery showed an initial occlusion of all ICPV, however after 20 weeks only 
43% was occluded. Contrary to USGS, CPS does not require an intraluminal approach of the 
ICPV. Even placed extraluminal, the cryoprobe will attach to the ICPV. This makes the treatment 
of small-diameter ICPV easier with CPS than with ultrasound-guided sclerotherapy. CPS has 
the potential to treat ICPV but needs some alterations to gain a higher success rate. There are 
two explanations for the low success rate of 43%. The first explanation is related to the learning 
curve of this procedure. CPS is a complete new technique for the treatment of ICPV, which needs 
close cooperation between the surgeon and the vascular technician. The second explanation 
is related to the smooth surface of the cryoprobe used. During vigorous withdrawal, the ice 
cone often detaches from the tip of the cryoprobe. The integrity of the ICPV is, therefore, left 
unharmed as one fails to achieve the intended obliteration. The perioperative duplex cannot 
determine the level of damage as the ICPV thromboses as a result of cryomanipulation. After 
analyzing the results of this study, the surface of the tip of the probe was made rough by 
coating it with diamond dust (Figure 8). An extensive bench test was performed to determine 
pull strength of the original cryoprobe versus a diamond dust coated cryoprobe. The diamond 
dust coated cryoprobe was 3.6 times stronger than the original cryoprobe. 
Figure 8
A study on CPS with the new diamond dust-coated cryoprobe will be performed. This study 
showed that CPS is feasible for the treatment of ICPV. Major advantages are that regardless of 
their anatomic location, all ICPV can be treated in an outpatient setting under local anesthesia 
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and the cryoprobe does not need intraluminal insertion in the ICPV. Another advantage is that 
the cryoprobe is reusable.
Radiofrequency ablation of ICPV seems feasible, with a success rate of 79% after one year and 
76% after two years. Just like USGS there is the need for intraluminal insertion of the RF catheter 
in the ICPV, which makes it less useful for small caliber ICPV. From the series mentioned no 
intention to treat data are available so we do not know how many time it was impossible to 
puncture the ICPV properly. But the occlusion rate after one year looks acceptable but far from 
optimal. A disadvantage is that the system is disposable and therefore expensive.
LASER ablation of ICPV is possible with a high success rate of almost 100%, however just like 
USGS and RF ablation the LASER catheter needs to be intraluminal of the ICPV, which makes it 
unsuitable for the small caliber ICPV. Most disturbing side effect was a paresthesia incidence of 
16%, which was probably due to thermal damage of surrounding nerves. Coil embolisation of 
ICPV is shown to be unsuccessful.
The duplex directed disruption of ICPV is a supra-fascial technique that also does not need 
an intraluminal approach. As stated it is easy and cheap. The results seem promising but it 
can be theorized that because the entrance in the subcutaneous tissue has to be through a 
small incision in healthy skin the distance to the ICPV can be long causing more subcutaneous 
damage. The percutaneous direct approach with the cryoprobe might reduce this possible 
problem.
CONCLUSION
All these new techniques seem feasible in the treatment of ICPV. Cryo perforator surgery and 
duplex directed interruption of ICPV have an extra advantage to be an extraluminal treatment 
of ICPV and they are easy and cheap. Again, randomized controlled trials have to be performed 
to recommend any of these techniques above another. 
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ABSTRACT
Purpose: This study was conducted to determine the feasibility of cryoperforator surgery in 
the treatment of incompetent perforating veins. 
Methods: Fifteen patients with C2-C4 varicose disease (according to the Clinical-Etiology-
Anatomy-Pathophysiology classification) were enrolled in this study. Under local anesthesia, 
incompetent perforating veins were treated with a duplex-guided cryoprobe. Duplex 
scans were performed 2 and 4 weeks after treatment. Fifteen patients with 28 incompetent 
perforating veins were treated with cryoperforator surgery. Distribution of the incompetent 
perforating veins was as follows: posterior tibial perforator, 12; paratibial perforator, 11; 
intergemellar perforator, 1; lateral leg perforator, 4 (range = 1-5 incompetent perforating veins 
per patient). 
Results: Follow-up showed successful treatment of 12 incompetent perforating veins (43%). 
Conclusions: This study showed that cryoperforator surgery is feasible for treatment of 
incompetent perforating veins. Higher success rates could be obtained with our modified 
diamond-dust coated cryoprobe. Major advantages are the treatment in an outpatient setting 
and the possibility of treating all incompetent perforating veins, intraluminal or extraluminal.
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INTRODUCTION
Worldwide, chronic venous diseases involve enormous costs for their treatment.1,2
Venous ulcers account for the majority of morbidity and treatment costs because of the slow 
healing and high recurrence rate. Treatment of the superficial venous system, in combination 
with dissection of incompetent perforating veins (ICPV), is perceived to be the best treatment 
for patients with chronic venous leg ulceration (C6 according to Clinical-Etiology-Anatomy-
Pathophysiology [CEAP] classification).3,4 Improvements in surgical techniques could bring 
down costs and result in a higher patient satisfaction. There are various ways by which the 
superficial venous system can be surgically treated, such as classic stripping, cryostripping, 
radiofrequency ablation, and endovenous laser treatment of the great saphenous vein (GSV) or 
crossectomy of the small saphenous vein (SSV). Treatment of venous ulcers in areas above the 
ankle due to venous hypertension should involve the dissection of ICPV in combination with 
treatment of the incompetent superficial venous system. The objective of ICPV dissection is to 
decrease venous reflux and to reduce ambulatory venous hypertension. Dissection of ICPV can 
be done with subfascial endoscopic perforating vein surgery (SEPS), open perforantectomy, 
or ultrasound-guided sclerotherapy. Subfascial endoscopic perforating vein surgery was first 
performed by Dr G. Hauer5 in Germany in 1985. For many vascular surgeons, it is currently the 
surgical technique of choice in treating ICPV. In inexperienced hands, SEPS can show poor results 
because of a challenging learning curve. Subfascial endoscopic perforating vein surgery is also 
known to have other limitations. This technique is mainly suitable for the treatment of ICPV 
on the medial aspect of the lower leg.6 The narrow confines due to compartmental tapering 
at the ankle have proven challenging for SEPS. Ultrasound guided sclerotherapy for treating 
ICPV showed poor long-term results in our clinic, and its use is not widespread. Cryoperforator 
surgery (CPS) was developed in our vascular laboratory as a new treatment of dissecting ICPV. 
Cryoperforator surgery is a minimal invasive technique, which provides unlimited access to all 
ICPV regardless of their location and can be performed under local anesthesia. In this article, 
we describe our study regarding the feasibility of CPS in treating ICPV.
PATIENTS AND METHODS
Over a period of 6 months, 15 patients with C2-C4 varicose veins (according to the CEAP 
classification) were enrolled in this study. An informed consent was obtained from all patients 
before surgery. A prospective registry of preoperative and postoperative duplex scans 
was created. During the duplex scan, incompetence or obliteration of the ICPV was noted, 
indicating the success of the treatment. Cryoperforator surgery was applied in patients with 
clinical complaints of chronic venous disease such as pain, fatigue, and heavy feeling of the 
leg. All patients had a competent deep venous system, and their superficial venous system 
was either competent or already treated. Therefore, the venous complaints could only be due 
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to ICPV. Contraindications to participate in this study were peripheral arterial disease (ankle 
brachial index < 0.9), GSV or SSV incompetence, and incompetence or occlusion of the deep 
venous system. Because the effects of CPS in the proximity of a venous (healed) ulcer were 
uncertain, avoiding every risk, patients with C5 and C6 varicose veins were not enrolled in this 
study.
 
Duplex Scanning
Before treatment, all ICPV were identified and ink marked on the skin, using a duplex ultrasound 
with an ATL 5000 scanner (Advanced Technology Laboratories, Bothel, Washington) using a 5- 
to 12-MHz linear array transducer. Incompetence was defined when perforator reflux times 
exceeded 0.35 seconds.7
Operation
The operation was performed under local anesthesia (1% lidocaine). The ICPV were 
approached percutaneously, placing a 14-gauge cannula (Venflon; BD Medical, Swindon, 
United Kingdom) at the fascia defect under duplex ultrasound guidance. The cannula could 
be placed intraluminal or extraluminal small-diameter ICPV. The cryoprobe (Erbe, Tübingen, 
Germany), with a diameter of 1.6 mm, was introduced through the cannula and frozen for 
15 seconds at -89°C (liquid nitrous oxide, N2O). During the freezing, an ice cone was formed 
at the tip of the cryoprobe. The ICPV was freeze-attached to the ice cone, and dissection was 
obtained by withdrawing the probe vigorously. Treatment was considered successful peri-
operative when ICPV showed no signs of flow despite augmentation on the duplex scan. A 
compression bandage was applied in all patients and they were discharged 1 hour after the 
operation. Follow-up duplex scans were performed 2, 4, and 20 weeks after treatment. Total 
follow-up for all patients was 20 weeks.
RESULTS
Patients consisted of 3 men and 12 women with a median age of 55 years (age = 22-76 years) 
and complaints of chronic venous disease. There was no comorbidity. Preoperative duplex 
scanning showed 28 ICPV in 15 patients. All ICPV were treated with CPS. Distribution of the 
ICPV was as follows: posterior tibial perforator, 12; paratibial perforator, 11; intergemellar 
perforator, 1; lateral leg perforator, 4 (range = 1-5 per patient). The diameter (median) of the 
fascia defect was 2.8 mm (range = 1.8-6.8 mm) and depth (median) of the fascia defect was 
10.4 mm (range = 3.7-22.0 mm). Perioperative duplex showed no signs of flow in all treated 
ICPV. Follow-up duplex after 2, 4, and 20 weeks showed successful treatment in 12 perforating 
veins (43%; Table 1). Distribution of perforating veins in successful treatment: posterior tibial 
perforator, 4; paratibial perforator, 6; intergemellar perforator, 0; lateral leg perforator, 2. There 
were no perioperative complications. Five patients developed a small hematoma on the leg, 
which healed within 2 weeks. All patients completed the follow-up period.
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Table 1: Results of Cryoperforator Surgery
Main group Subgroup  Depth, mm Diameter, mm Successful
Leg perforator Posterior tibial perforator (upper) 3.7 2.2 Yes
Posterior tibial perforator (upper) 10.2 2.4 No
Posterior tibial perforator (upper) 10.0 2.0 Yes
Posterior tibial perforator (middle) 9.5 2.2 No
Posterior tibial perforator (middle) 11.0 3.9 No
Posterior tibial perforator (middle) 9.2 2.0 No
Posterior tibial perforator (lower) 9.0 6.8 Yes
Posterior tibial perforator (lower) 7.2 3.2 No
Posterior tibial perforator (lower) 21.0 2.1 No
Posterior tibial perforator (lower) 21.7 1.8 No
Posterior tibial perforator (lower) 21.7 1.9 No
Posterior tibial perforator (lower) 6.1 6.8 Yes
Paratibial perforator 10.0 2.5 Yes
Paratibial perforator 10.0 2.6 Yes
Paratibial perforator 13.0 3.8 Yes
Paratibial perforator 13.5 2.6 Yes
Paratibial perforator 13.8 2.1 Yes
Paratibial perforator 9.1 6.2 No
Paratibial perforator 10.5 4.9 No
Paratibial perforator 14.4 4.0 No
Paratibial perforator 13.6 3.0 Yes
Paratibial perforator 5.7 3.6 No
Paratibial perforator 22.0 4.1 No
Intergemellar perforator 11.6 5.2 No
Lateral leg perforator 6.5 2.9 No
Lateral leg perforator 6.8 3.9 Yes
Lateral leg perforator 22.0 2.2 No
Lateral leg perforator 18.7 2.4 Yes
Media  10.4 2.8
Range  3.7-22.0 1.8-6.8 12/28 (43%)
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DISCUSSION
Venous leg ulceration accounts for a large percentage of total health budget. The desired 
procedure of this condition is the treatment of the superficial venous system in combination 
with dissection of ICPV. Until now, SEPS or open perforantectomy is the most commonly 
applied procedures for dissecting ICPV. A less invasive, outpatient treatment could lower 
morbidity and costs. Cryoperforator surgery has the potential to become an alternative to the 
conventional treatments applied today. Our study was performed to determine the feasibility 
of CPS. Our study shows that there are several advantages of CPS compared to SEPS and 
ultrasound guided sclerotherapy. Contrary to SEPS, CPS can reach all ICPV regardless of their 
anatomical location, resulting in a more extensive therapeutic range. Cryoperforator surgery 
can be performed under local anesthesia in an outpatient clinic setting and is less invasive 
than SEPS. In our clinic, ultrasound guided sclerotherapy showed poor long-term results, but 
good results were presented by Masuda et al.8 Contrary to this technique, CPS does not require 
an intraluminal approach of the ICPV. Even in extraluminal, the cryoprobe will attach to the 
ICPV. This makes the treatment of small-diameter ICPV easier with CPS than with ultrasound-
guided sclerotherapy. Treatment of ICPV with radiofrequency ablation (Closure catheter, VNUS 
Medical Technologies, Sunnyvale, CA) or laser has been performed but shows no convincing 
long-term efficacy.9,10 We have found that CPS has the potential to treat ICPV but needs some 
alterations to gain a higher success rate. There are two explanations for the low success rate 
of 43%. The first explanation is related to the learning curve of this procedure. Cryoperforator 
surgery is a complete new technique for the treatment of ICPV, which needs a close cooperation 
between the surgeon and the vascular technician. The second explanation is related to the 
smooth surface of the cryoprobe used. During vigorous withdrawal, the ice cone often detach 
from the tip of the cryoprobe. The integrity of the ICPV is, therefore, left unharmed as one fails 
to achieve the intended obliteration. The perioperative duplex cannot determine the level of 
damage as the ICPV thromboses as a result of cryo manipulation. After analyzing the results of 
this study, the surface of the tip of the probe was made rough by coating it with diamond dust. 
An extensive bench test was performed to determine pull strength of the original cryoprobe 
versus a diamond dust coated cryoprobe. The diamond dust-coated cryoprobe was 3.6 times 
stronger than the original cryoprobe. A study on CPS with the new diamond dust-coated 
cryoprobe was further carried out. This study showed that CPS is feasible for the treatment of 
ICPV. Major advantages are that regardless of their anatomic location, all ICPV can be treated 
in an outpatient setting under local anesthesia, and the cryoprobe does not need intraluminal 
insertion in the ICPV. In conclusion, CPS is feasible for the treatment of ICPV. Higher success 
rates can be obtained with the modified diamond-dust cryoprobe. Major advantages are the 
minimal-invasive treatment in an outpatient setting and the possibility of reaching all ICPV, 
intraluminal or extraluminal.
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ABSTRACT
Purpose: Cryo perforator surgery (CPS) showed in a earlier study that it could be an effective 
surgical technique in the treatment of ICPV. Modification of the cryoprobe with a diamond 
dust coating (DDC) showed better results in vitro. A second study was performed to determine 
the efficacy and safety of CPS with the DDC cryoprobe.
Methods: All patients had clinical complaints and ICPV. CPS consisted of DDC cryoprobe 
insertion in or near the ICPV. The efficacy of the procedure was determined with duplex 
ultrasound, 1 month after the procedure.
Results: Eleven women with 15 ICPV were treated with CPS. In 2 patients (18%) the treatment 
was successful with 3 occluded perforating veins (20%). One patient developed a persistent 
painfully paresthesia on the medial side of the lower leg.
Conclusions: CPS cannot perform a dissection of ICPV. It is a painful and difficult procedure 
with a disturbing success rate. CPS should be considered obsolete.
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INTRODUCTION
There is still no definitive consensus if treatment of the superficial venous system, in 
combination with dissection of incompetent perforating veins (ICPV), is the best treatment 
for patients with chronic venous leg ulceration.1-3 Improvements in surgical techniques for 
treatment of ICPV have the potential to reduce costs and result in a higher patient satisfaction. 
There are numerous techniques by which the superficial venous system can be surgically 
treated. Conventional stripping, cryo stripping, radiofrequency thermo ablation, and laser 
thermo ablation for the great saphenous vein. Ligation or laser thermo ablation for the small 
saphenous vein. 
Treatment of active venous ulcers in the area above the ankle could involve the dissection of ICPV 
in combination with treatment of the incompetent superficial venous system. The idea behind 
ICPV dissection is to decrease venous reflux and to reduce ambulatory venous hypertension. 
Dissection of ICPV can be done with subfascial endoscopic perforating vein surgery (SEPS), 
open perforantectomy, ultrasound guided sclerotherapy and laser or radiofrequency thermo 
ablation. For many vascular surgeons, SEPS is the surgical technique of choice in treating 
ICPV, however it can show poor results because of a challenging learning curve. SEPS is also 
mainly suitable for the treatment of ICPV on the medial aspect of the lower leg and the narrow 
confines due to compartmental tapering at the ankle have proven challenging.4,5 Ultrasound 
guided sclerotherapy for treating ICPV showed poor long-term results in our hospital, and its 
use is not widespread. The treatment of ICPV with radiofrequency or laser thermo ablation is a 
rather new technique which has to show its potential in future trials. 
Cryo perforator surgery (CPS) showed in an earlier study that it could treat ICPV, however there 
was a large percentage (57%) of unsuccessful procedures.6 CPS was developed in our vascular 
laboratory as a new treatment of dissecting ICPV. It is a minimal invasive technique, which 
provides unlimited access to all ICPV regardless of their location and can be performed under 
local anesthesia. After analysis of the results of the earlier CPS study, the new hypothesis was 
that the smooth surface of the cryoprobe was the reason for the low success rate. A more 
rough (increased) surface by means of diamond dust coating (DDC) of the cryoprobe could 
increase the number of successful procedures. In this article, we describe the feasibility of CPS 
in treating ICPV with a DDC cryoprobe.
PATIENTS AND METHODS
Over a period of 4 months, 11 patients with clinical severity class 2-4 venous disease were 
enrolled in this study. An informed consent was obtained from all patients before surgery. A 
prospective registry of preoperative and postoperative duplex scans was created. During the 
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duplex scan, incompetence or obliteration of the ICPV was noted, indicating the success of 
the treatment. CPS was applied in patients with clinical complaints of chronic venous disease 
such as pain, fatigue, and heavy feeling of the leg. All patients had a competent deep venous 
system, and their superficial venous system was either competent or already treated. Therefore, 
the venous complaints could only be due to ICPV. Contraindications to participate in this 
study were peripheral arterial disease (ankle brachial index < 0.9), GSV or SSV incompetence, 
and incompetence or occlusion of the deep venous system. Because the effects of CPS in the 
proximity of a venous (healed) ulcer were uncertain, avoiding every risk, patients with clinical 
severity class 5-6 venous disease were not enrolled in this study.
 
Duplex Scanning
Before treatment, all ICPV were identified and ink marked on the skin, using duplex ultrasound 
with an ATL 5000 scanner (Advanced Technology Laboratories, Bothel, Washington) using a 
5- to 12 MHz linear array transducer. Incompetence was defined when perforator reflux times 
exceeded 0.35 seconds.7
Conventional cryoprobe and DDC cryoprobe
A conventional cryoprobe (Erbe, Tübingen, Germany) has a diameter of 1.6 mm and a smooth 
metallic surface. After freezing for 15 seconds at -89°C (liquid nitrous oxide, N2O) an ice cone 
will form at the tip of the probe which attaches to the adherent venous structure. After pulling 
the probe the adherent venous structure will be destroyed. After analysis of the results of the 
earlier study we came to the conclusion that detachment of the ice cone from the cryoprobe 
was the main reason for the high failure rate. The integrity of the ICPV is left unharmed as one 
fails to achieve the intended obliteration. A conventional cryoprobe was coated on the tip (1.5 
cm) with diamond dust (Ackermann Instrumente, Rietheim-Weilheim, Germany). After bench 
testing the rough (increased) surface of the DDC cryoprobe resulted in an 3.6x increased pull 
strength. This DDC cryoprobe was further used in this study.
Operation
The operation was performed under local anesthesia (1% lidocaine). The ICPV were 
approached percutaneously, placing a 14-gauge cannula (Venflon; BD Medical, Swindon, 
United Kingdom) at the fascia defect under duplex ultrasound guidance. The cannula could be 
placed intraluminal or extraluminal in small diameter ICPV. The DDC cryoprobe was introduced 
through the cannula and frozen for 15 seconds. During the freezing, an ice cone was formed 
at the tip of the DDC cryoprobe. The ICPV was freeze attached to the ice cone, and dissection 
was obtained by withdrawing the probe vigorously. Treatment was considered successful 
perioperative when ICPV showed no signs of flow despite augmentation on the duplex scan. 
A compression bandage was applied in all patients and they were discharged 1 hour after the 
operation. Follow-up duplex scan was performed 4 weeks after treatment and a final physical 
examination 8 weeks after treatment. Total follow-up for all patients was 8 weeks.
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RESULTS
Patients consisted of 11 women with a median age of 61 years (age = 40-87 years) and complaints 
of venous disease. There was no diabetes or cardiopulmonal comorbidity. Preoperative duplex 
scanning showed 15 ICPV in 11 patients. All ICPV were treated with CPS. Distribution of the 
ICPV was as follows: thigh perforators, 6; leg perforators, 9. The median diameter of the ICPV 
was 4 mm (range = 2.0 - 6.2 mm). Perioperative duplex showed no signs of flow in all treated 
ICPV. Follow-up duplex after 4 weeks showed successful treatment in 3 perforating veins (20%) 
in 2 patients (18%) (Table 1). Distribution of perforating veins in successful treatment: thigh 
perforator, 1; leg perforator, 2. There was one complication: one patient had a persistent painful 
paresthesia of the medial aspect of the leg after CPS of a thigh perforator (femoral canal). This 
was probably caused by a lesion of the saphenous nerve or deeper side branch of the femoral 
nerve. Four patients developed a small hematoma on the leg, which healed within 2 weeks. All 
patients complained of pain during CPS. All patients completed the 8 week follow-up period. 
Because of these troublesome results no further patients were included in this study.
Table 1: Results of Cryoperforator Surgery
Main group Subgroup  Depth, mm Diameter, mm Successful
Leg perforator Posterior tibial perforator (upper) 3.7 2.2 Yes
Posterior tibial perforator (upper) 10.2 2.4 No
Posterior tibial perforator (upper) 10.0 2.0 Yes
Posterior tibial perforator (middle) 9.5 2.2 No
Posterior tibial perforator (middle) 11.0 3.9 No
Posterior tibial perforator (middle) 9.2 2.0 No
Posterior tibial perforator (lower) 9.0 6.8 Yes
Posterior tibial perforator (lower) 7.2 3.2 No
Posterior tibial perforator (lower) 21.0 2.1 No
Posterior tibial perforator (lower) 21.7 1.8 No
Posterior tibial perforator (lower) 21.7 1.9 No
Posterior tibial perforator (lower) 6.1 6.8 Yes
Paratibial perforator 10.0 2.5 Yes
Paratibial perforator 10.0 2.6 Yes
Paratibial perforator 13.0 3.8 Yes
Paratibial perforator 13.5 2.6 Yes
Paratibial perforator 13.8 2.1 Yes
Paratibial perforator 9.1 6.2 No
Paratibial perforator 10.5 4.9 No
Paratibial perforator 14.4 4.0 No
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Table 1: Results of Cryoperforator Surgery
Main group Subgroup  Depth, mm Diameter, mm Successful
Paratibial perforator 13.6 3.0 Yes
Paratibial perforator 5.7 3.6 No
Paratibial perforator 22.0 4.1 No
Intergemellar perforator 11.6 5.2 No
Lateral leg perforator 6.5 2.9 No
Lateral leg perforator 6.8 3.9 Yes
Lateral leg perforator 22.0 2.2 No
Lateral leg perforator 18.7 2.4 Yes
Media  10.4 2.8
Range  3.7-22.0 1.8-6.8 12/28 (43%)
DISCUSSION
Venous leg ulceration accounts for a large percentage of total health budget.8 Although 
there is no definitive consensus, most physicians believe that the desired procedure of this 
condition is the treatment of the superficial venous system in combination with dissection 
of ICPV. SEPS or open perforantectomy are still commonly applied procedures for dissecting 
ICPV. Less invasive, outpatient treatment could reduce morbidity and costs. In theory CPS has 
many advantages like intra or extra- luminal treatment of ICPV regardless of their anatomical 
location and treatment under local anesthesia in an outpatient clinic setting. CPS however has 
shown in this study that it cannot perform an adequate dissection of ICPV. 
The explanation for the low success rate of 20% is not fully understood. There is definitively a 
learning curve effect of this procedure. CPS needs a close cooperation between the surgeon 
and the vascular technician. The DDC cryoprobe was expected to perform better in patients, 
as it did in vitro, when compared to the conventional cryoprobe. Perioperative assessment 
of the ICPV is difficult as the duplex scan cannot determine the level of damage as the ICPV 
thromboses as a result of cryo manipulation. 
In theory, freezing time could have resulted in these low success rates. In 15 seconds a rather 
large ice-cone will form around the cryoprobe which adheres to all surrounding tissues. When 
freezing times are shortened a smaller ice cone will form and more selective adherence of 
the ICPV could occur. The reason for the higher success rate in the earlier study with the 
conventional cryoprobe could be the fact that the median diameter of ICPV was smaller (2.8 
Chapter 8
103
CRYO perforator surgery: results with a modified probe
mm) compared to this group of patients (4.0 mm). In this study also patients with incompetent 
thigh perforators were treated, which are situated rather deeper than leg perforators.
Because of the low success rates of CPS, the fact that it is a painful procedure and the persistent 
neural damage in one patient our department stopped using CPS.
Our conclusion is that CPS cannot perform a dissection of ICPV, it is a difficult and painful 
procedure with a disturbing success rate and it should be considered obsolete. 
Minimally invasive techniques for dissection of ICPV could be in the form of radiofrequency or 
laser thermo ablation. These modalities have to show their potential in future trials.
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SUMMARY AND CONCLUSIONS
This thesis describes studies on the aspect of venous cryo surgery of the leg and quality of 
life measurement. In chapter 1, the rationale for this research is presented. Venous disease of 
the leg has an estimated prevalence of 60% and accounts for substantial morbidity, costs and 
loss in quality of life. Small changes in (surgical) therapy can therefore have large effects. The 
alternative therapy, cryo stripping, is introduced in the light of anatomical, epidemiological, 
etiological and socio-economic aspects of venous disease of the leg.
To measure quality of life in a Dutch population with venous disease of the leg, a validated quality 
of life questionnaire was necessary. In chapter 2, a health specific quality of life questionnaire 
(Aberdeen Varicose Vein Questionnaire) was validated, according to international guidelines, 
for the Dutch language.
In chapter 3, the use of the Dutch translated Aberdeen Varicose Vein Questionnaire was 
evaluated. This study showed that the questionnaire could differentiate between groups of 
patients with different severity classes of venous disease and groups before and after therapy.
A review of all surgical techniques for the treatment of the incompetent great saphenous vein 
is presented in chapter 4. Surgical stripping of the great saphenous vein is still used in the 
majority of cases. Minimally invasive methods like laser and radiofrequency thermo ablation 
have gained popularity in the last decade. We conclude that all treatment modalities appear 
to be effective and safe with short and midterm follow up. Before considering endovenous 
treatments as first choice treatment, large high quality randomized trials with long term follow 
up are needed.
In chapter 5 the results are described of a prospective randomized trial, comparing the results 
of conventional stripping to cryo stripping of the incompetent great saphenous vein. The 
primary outcome was residual great saphenous after 6 months, confirmed by duplex ultrasound. 
Secondary outcomes were quality of life measurements, neural damage and operation time. 
The conclusion is that cryo stripping with a rigid cryoprobe accounts for numerous procedural 
failures and hence residual GSV in patients. Health-related QOL measured by the AVVQ showed 
small but significantly better results for patients after conventional stripping. Cryo stripping 
has no benefits over conventional stripping.
In chapter 6 indications and different techniques are reviewed in the minimally invasive 
treatment of incompetent perforating veins. SEPS is not considered minimally invasive when 
new treatments like laser, radiofrequency ablation and CPS are available. Further studies will 
shed light which treatment should become the new gold standard.
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In chapter 7 the results are described of a cohort patients with incompetent perforating veins 
who received Cryo Perforator Surgery (CPS). In this study poor results were found which were 
probably related to the smooth surface of the cryoprobe.
With a modified cryoprobe which was coated with diamond dust, a new cohort patients 
with incompetent perforating veins was treated. The results are described in chapter 8. The 
conclusion is that CPS give very poor results and should be considered obsolete.
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SAMENVATTING EN CONCLUSIES
Dit proefschrift beschrijft studies met betrekking tot veneuze cryo chirurgie van het been en 
‘Quality of life’ metingen. In hoofdstuk 1, wordt de rationale voor dit onderzoek uitgelegd. 
Veneuze ziekte van het been heeft een geschatte prevalentie van 60% en een substantiële 
morbiditeit, kosten en verlies van ‘quality of life’. Kleine veranderingen in (chirurgische) 
therapie kunnen daardoor grote effecten hebben. De alternatieve cryo strip behandeling 
wordt geïntroduceerd in het kader van anatomische, epidemiologische, etiologische en socio-
economische aspecten van veneuze ziekte van het been.
Om ‘quality of life’ te meten in een Nederlandse populatie met veneuze ziekte van het 
been was het noodzakelijk dat er een gevalideerde ‘quality of life’ questionnaire kwam. In 
hoofdstuk 2, wordt een ziekte specifieke ‘quality of life’ questionnaire (Aberdeen Varicose Vein 
Questionnaire) gevalideerd voor de Nederlandse taal.
In hoofdstuk 3, wordt het gebruik van de Nederlands vertaalde Aberdeen Varicose Vein 
Questionnaire geëvalueerd. Deze studie kwam tot de conclusie dat de questionnaire prima 
kon differentiëren tussen groepen patiënten met verschillende ernst van veneuze ziekte voor 
en na behandeling.
Een overzicht van alle chirurgische technieken voor behandeling van de insufficiënte vene 
saphena magna wordt beschreven In hoofdstuk 4. De klassieke chirurgische strip wordt nog zeer 
veel gebruikt wereldwijd. Minimaal invasieve methoden zoals laser en radiofrequency ablatie 
zijn in korte tijd zeer populair geworden. De conclusie is dat alle behandelingsmethoden veilig 
en geschikt zijn voor de behandeling op korte en middellange termijn. Voordat endoveneuze 
behandeling de behandeling van eerste keuze wordt zijn er meer grote gerandomiseerde 
studies noodzakelijk met een lange follow-up termijn. 
In hoofdstuk 5 worden de resultaten beschreven van een prospectief gerandomiseerde trial. 
Hierin wordt de conventionele strip vergeleken met een cryostrip van de insufficiënte vene 
saphena magna. Het primaire eindpunt was residu van de vene saphena magna, 6 maanden 
na behandeling, bevestigd door duplex ultrasound. Secundaire eindpunten waren ‘quality of 
life’ metingen, zenuwletsel en operatietijd. De conclusie is dat een cryo strip veel operatieve 
problemen geeft en daardoor een zeer teleurstellend resultaat oplevert. ‘Quality of life’ 
metingen Laten kleine maar significante verschillen zien ten voordele van de klassieke strip. 
De cryo strip heeft geen meerwaarde ten opzichte van een klassieke strip.
In hoofdstuk 6 worden de indicaties en verschillende technieken beschreven in de minimaal 
invasieve behandeling van insufficiënte perforatoren. SEPS is langere tijd de gouden standaard 
geweest, maar is in vergelijking met laser, radiofrequency ablatie en CPS niet echt minimaal 
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invasief. Verdere studies zullen moeten uitmaken wat de nieuwe gouden standaard gaat 
worden in de behandeling van insufficiënte perforatoren.
In hoofdstuk 7 worden de resultaten beschreven van een cohort patiënten met insufficiënte 
perforatoren die Cryo Perforator Surgery (CPS) ondergingen. In deze studie werden zeer slechte 
resultaten gevonden na deze behandeling. Het was waarschijnlijk dat de slechte resultaten te 
wijten waren aan het gladde oppervlak van de cryoprobe.
Met een aangepaste cryoprobe, die een coating had gekregen met diamantstof werd een 
nieuw cohort patiënten behandeld met insufficiënte perforatoren. De resultaten werden 
beschreven In hoofdstuk 8. De conclusie is dat CPS zeer matige resultaten oplevert en dat het 
als een obsolete behandeling moet worden beschouwd.
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